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ABSTRACT
IQGAP1 Knockdown Enhances the Endothelial Barrier In Vitro
Wentao Zhang
IQGAP1 overexpression inhibits E-cadherin-mediated epithelial cell-cell adhesion by
distabilizing the adherens junctions, and activated Rac1 and Cdc42 may prevent these
effects by removing IQGAP1 from the adherens junction complex. In the present
study, we determined if IQGAP1 associates with the adherens junction of endothelial
cells and affects endothelial barrier function. In human umbilical vein endothelial
cells (HUVECs), IQGAP1 associated with VE-cadherin, the catenins, β, γ, α, and
p120, but not with N-cadherin or the tight junction proteins, occludin, claudin-5, and
ZO-1. Detergent extracted most of the IQGAP1 associated with VE-cadherin.
Treatment of endothelial cells with sphingosine-1-phosphate (S1P), which increases
the activity of Rac1, increased the association of IQGAP1 with Rac1, and the amount
of insoluble VE-cadherin and β-catenin at intercellular junctions. To determine if the
increased localization of junctional VE-cadherin induced by S1P occurred via the
removal of IQGAP1, the protein level of IQGAP1 was reduced with small interfering
RNA or siRNA. Reduction of IQGAP1 by transfection of siRNA resulted in a higher
endothelial electrical resistance in HUVECs as compared to transfection of a
scrambled siRNA. Reduction of IQGAP1 also induced an increase and a decrease,
respectively, in the protein levels of VE-cadherin and N-cadherin. Also, more VEcadherin and less N-cadherin were associated with p120 and β-catenin. Furthermore,
more insoluble (cytoskeletal-associated) VE-cadherin was localized at intercellular
junctions and less insoluble N-cadherin was present in HUVECs. Overexpression of
a VE-cadherin-α-catenin fusion protein, which lacked the binding sites for β-catenin
on VE-cadherin and α-catenin, diminished the localization of junctional IQGAP1.
These findings suggest that IQGAP1 knockdown positively influences the endothelial
barrier by increasing the protein level of VE-cadherin and the interaction of VEcadherin with the cytoskeleton, possibly by enhancing the p120-VE-cadherin
association.
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I. LITERATURE REVIEW
A. Endothelial Cell-Cell Junctions
Intercellular junctions, including adherens junctions (or zonula adherens), tight
junctions (or zonula occludens) and gap junctions, connect adjacent vascular
endothelial cells and impart a semi-permeable barrier to the passage of water and
proteins. The presence and organization of these junctional complexes depend on the
type of blood vessel and the permeability requirements of the perfused organs. Gap
junctions mediate cell-to-cell communication by allowing the passage of small
molecular weight solutes between neighboring cells. Tight junctions as “a barrier”
and “a fence” are responsible, respectively, for regulating paracellular permeability
and maintaining cell polarity. Endothelial adherens junctions are involved in cell-cell
recognition, contact inhibition of cell growth, and paracellular permeability to
circulating leukocytes and solutes (4). This dissertation focuses mainly on molecular
organization and functions of adherens junctions in endothelial cells. The regulation
mechanisms of adherens junctions will also be discussed in this literature review.
1. Vascular Permeability
Vascular endothelia form a selective barrier between blood and the
extravascular space that controls the passage of fluid, electrolytes, proteins and even
cells. As a barrier, vascular endothelia regulate many biological processes such as
inflammation, white cell emigration, and angiogenesis. Disruption of the endothelial
barrier leads to accumulation of fluid and macromolecules in the interstitial space,
resulting in edema and dysfunction of tissues and organs and distant metastasis of
cancer cells. In normal (undisturbed) tissues, proteins are transported by transcytosis
through plasmalemmal vesicles and channels and their uncharged diaphragms and
paracellularly through intercellular junctions (61). During normal inflammatory
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processes, plasma and some blood cells can pass paracellularly through intercellular
junctions transiently separated by vasoactive mediators, such as histamine, bradykinin,
serotonin, and platelet-activating factor.
An excessive inflammatory response as well as growth factors, cytokines,
and reactive oxygen species can activate the microvascular and venular endothelia to
elicit intracellular signaling reactions that compromise endothelial barrier function
(112). Activated leukocytes and cancer cells of high metastatic capacity also have the
potential to breakdown the integrity of the vascular endothelial barrier. Vascular
endothelial growth factor (VEGF)-expressing ID8 murine ovarian carcinoma cells,
injected intravenously into the tail vein of mice, formed more metastatic lesions in the
lung than did injection of control cells. The high level of VEGF disrupted endothelial
cell-cell junctions and contributed to tumor cell extravasation and metastasis (103).
Therefore, the maintenance and regulation of the endothelial barrier is important
physiologically and pathologically.
Water, electrolytes, and small molecules can exchange freely between blood
and extravascular compartments by diffusion and bulk flow. They may pass through
the cell via vesicles and membrane channels or parcellularly via fenestrae and
intercellular junctions. The rate of exchange is determined by hydrostatic pressure,
oncotic pressure, and the permeability of the capillary wall. Permeability is usually
assessed by hydraulic conductivity (Lp), the diffusional permeability coefficient (Pd),
and/or the reflection coefficient (σ). Hydraulic conductivity is the flow of water
through a unit area of vessel wall per unit difference in hydrostatic pressure across the
wall (Lp=(Jv/A)/ΔP, when the osmotic pressure is held constant or Δπ=0). The
diffusional permeability coefficient is the mass transport of a substance per unit
concentration difference, under conditions when the net fluid flow through the
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capillary wall is zero (Pd= (Js/A)/ΔC, when Jv=0) or held constant. The reflection
coefficient compares the penetration of a solute with that of the solvent through a
membrane (σf =1- Js/ JvC, when ΔC=0). If the membrane is impermeable to a solute,
σ=1; if the membrane is totally permeable to a solute, σ=0 (60).
2. Adherens Junctions
Along the vascular tree, adherens junctions are ubiquitously distributed and
expressed at the periphery of endothelial cells. Adherens junctions consist mainly of
cadherin-catenin complexes.
a. Cadherins
Over 80 members of the cadherin superfamily are expressed within a single
mammalian species and each cadherin has a unique tissue-distribution pattern.
Endothelial cells express at least five cadherins: N-cadherin (neural cadherin), Pcadherin (placental cadherin) (54), T-cadherin (78), Cadherin-5 or VE-cadherin
(vascular endothelial cadherin) and VE-cadherin 2 (or protocadherin 12, PCDH12)
(79). Among these cadherins, VE-cadherin is specifically localized to the interendothelial cell junction (49) and mediates calcium-dependent, homophilic binding of
endothelial cells through five extracellular cadherin repeats, a transmembrane region,
a juxtamembrane region, and a highly conserved cytoplasmic tail (1, 49). In the
presence of calcium, extracellular domains bind laterally to each other, forming cisdimers, or in a head-to-head manner with cadherins on adjacent cell, forming transdimers. Actually, VE-cadherin can confer strong cell-cell adhesion by forming cisdimers, trans-dimers, lateral clusters, and linkage with the actin cytoskeleton (101).
So, VE-cadherin plays an important role in the regulation of vascular permeability
(27). But when Carmeliet et al. (1999) generated mice that lacked a functional
Cadherin-5 (VE-cadherin) gene, which expressed a mutant Cadherin-5 gene lacking
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the beta-catenin binding cytoplasmic tail, or that did not express a detectable
Cadherin-5 level, they found in all of these mice that deletion or truncation of the
Cadherin-5 gene affected the assembly of endothelial cells in vascular plexi, but not
completely, suggesting that other cadherin(s) may also mediate endothelial cell-cell
adhesion (9).
N-cadherin, another member of the classical cadherin family, is usually found
at cell-cell contact sites in tissues where it is expressed. In endothelial cells, Ncadherin remains diffusely distributed at the cell membrane (67) and is necessary for
sphingosine 1-phosphate (S1P)1 receptor-induced endothelial-mural cell interaction
(74). Thus, N-cadherin may promote endothelial cell adhesion and communication
with pericytes or smooth muscle cells expressing N-cadherin. Recent evidence shows
that N-cadherin also localizes to endothelial cell-cell junctions, indicating a possible
role of N-cadherin in mediating endothelial cell-cell adhesion (56). However, little is
known about N cadherin-mediated homotypic cell adhesion. Once calcium-dependent
homophilic binding of VE-cadherin or N-cadherin is disrupted, VE-cadherin or Ncadherin is internalized, possibly recycled or degraded (40), lowering the protein level
in cells.
Both VE- and N-cadherins can directly bind to shc, an adapter protein in the
Ras signaling pathway. And expression of VE-cadherin in confluent endothelial cell
monolayers induced Rac activation and Rho inhibition, but N-cadherin expression
induced the opposite and promoted cell migration (68).
The specific transmembrane protein of endothelial cells called cadherin-5 or
vascular endothelial (VE)-cadherin (15) binds p120 via its juxtamembrane domain,
and binds β-catenin and plakoglobin (δ-catenin) through its cytoplasmic tail or
catenin-binding domain. β-catenin and plakoglobin in turn link α-catenin, which also
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binds linker proteins such as vinculin, α-actinin, and ZO-1. These linker proteins and
the adhesion modulation domain of α-catenin link the VE-cadherin/β-catenin
complex to the actin cytoskeleton (48). The current dogma that the VE-cadherin/βcatenin complex links to to actin via α-catenin, however, has recently been challenged.
Two back-back publications by Drees et al. (16) and Yamada et al. (109) suggest that
α-catenin does not bind simultaneously to both the VE-cadherin/β-catenin complex
and to actin and that this purported linkage is more dynamic than originally thought.
Additional studies are required to determine the validity of this new hypothesis.
b. Catenins
Catenins (α, β, γ, and p120) are members of the Armadillo family, which is
characterized by a central domain that is composed of a series of imperfect 45-amino
acid repeats. Each catenin exerts several functions through interactions of its
armadillo repeat domain with diverse binding partners. The cytoplasmic tail of VEcadherin binds to β-catenin, which in turn binds to α-catenin to form a complex that
links to the actin cytoskeleton. γ-Catenin (plakoglobin) also interacts with VEcadherin and links the VE-cadherin complex with the actin cytoskeleton and/or
connects VE-cadherin to intermediate filaments (84). A fourth catenin, p120
(p120cas), was originally characterized as a substrate of v-Src kinase (81, 97, 111)
and associates with the juxtamembrane domain of VE-cadherin, inducing cadherin
clustering and stabilization of adherens junctions (14, 39, 105). In the complex of
VE-cadherin and catenins, α-catenin appears to be the only catenin that directly or
indirectly links to the actin cytoskeleton through linker proteins such as α-actinin,
vinculin, ZO-1, spectrin and a number of other molecules associated with the cadherin
complex (108).
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The incorporation of α-catenin into cadherin-catenin complexes was thought
to be necessary for cadherins to mediate cell-cell adhesion. α-Catenin binds to either
β- or γ-catenin through the same region, amino-terminal residues 54-148. The aminoterminal domain (aa 82-279) of α-catenin is also important for dimerization. Its
central segment can associate with α-actinin (through aa 325-394) and vinculin
(through aa 327-402). Amino acids 509-643 of α-catenin is called the adhesion
modulation domain. The carboxyl terminal fragments of α-catenin bind to actin
filaments and vinculin (through aa 697-906), as well as ZO-1 (through aa 631-906).
By interacting with all these proteins, α-catenin can not only link cadherin-catenin
complexes to the actin cytoskeleton but also regulate actin binding, bundling, and
polymerization (36, 100). But contrary to this notion, recent studies reported that αcatenin did not interact simultaneously with actin filaments and the E-cadherin-βcatenin complex (109).
β-Catenin contains N-terminal Ser/Thr phosphorylation sites (aa 33-45), an αcatenin binding region (aa 118-146), an APC (adenomatous polyposis coli) binding
domain, a Tcf (T cell factor)/LEF (lymphocyte enhancer binding factor) binding
region, a cadherin binding region, and a C-terminal transactivator region (aa 671781). In addition to mediating adherens junction assembly, β-catenin also transduces
Wnt/Wingless intracellular signals, which regulate embryonic cell fates and, if
inappropriately activated, contribute to tumorigenesis. In the absence of Wnt
signaling, the cytoplasmic level of β-catenin is kept low through interaction with a
degradation complex comprised of APC , Axin, PP2A (protein phosphatase 2A), and
GSK3 β (glycogen synthase kinase 3 β), as well as CK1 (casein kinase 1).
Progressive phosphorylation by CK1 and GSK3 β leads to ubiquitination and
proteasomal degradation of β-catenin. F box/WD-40-repeat protein, β-TrCP, serves
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as an intracellular receptor for phosphorylated β-catenin, forming a Skp1/Cullin/F
box protein β-TrCP (SCF β-TrCP) ubiquitin ligase complex that ubiquitinates β-catenin
(99). When Wnt, a secreted glycoprotein, binds to Frizzled receptors and activates
Wnt signaling, GSK3 β is removed from the degradation complex, resulting in
accumulation of unphosphorylated β-catenin in the cytoplasm, allowing the
translocation of β-catenin to the nucleus and subsequent gene induction via binding to
TCF/LEF (5, 85). In tumors, degradation of β-catenin is blocked due to mutation of
β-catenin or APC, which results in the formation of TCF/β-catenin complexes and
activation of oncogenes (85).
It is proposed that binding of cadherins to β-catenin prevents recognition of
degradation signals that are exposed in the unstructured cadherin cytoplasmic domain,
favoring a cell surface population of catenin-bound cadherins capable of participating
in cell adhesion (32). When β-catenin binds to cadherins, it is also stabilized and
retained at the cell membrane, reducing the pool of free β-catenin in the cytosol and
decreasing its transcriptional activity. Tyrosine phosphorylation of β-catenin,
especially tyrosine 654, decreases the affinity of β-catenin to the cytoplasmic tail of
E-cadherin, which may induce the detachment of β-catenin from the cadherin and
increase cytoplasmic and nuclear β-catenin. In contrast, serine phosphorylation of
specific residues in the cytoplamic tail of cadherins increases β-catenin association
with cadherins (33).
γ-Catenin is a major component of both adherens junctions and desmosomes.
Via its 13 central repeats, γ-catenin binds to desmoglein (Dsg), desmocollin (Dsc), αcatenin, and classical cadherins. When γ-catenin is linked to intermediate filaments
instead of actin filaments, it may be involved in formation of endothelial junctions
known as complexus adhaerentes, a novel desmosomal-like structure that is specific
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for endothelial cells because it consists of VE-cadherin, γ-catenin, desmoplakin,
vimentin, and intermediate filaments, but not desmocollin or desmoglein (83, 84).
The functional role of complexus adhaerentes is still not clear. γ-Catenin can also
form cytosolic protein complexes with APC to determine cell fate (76).
p120ctn can be found at intercellular junctions, in the cytoplasm, and in the
nucleus. Epidermal growth factor, platelet-derived growth factor, colony stimulating
factor-1, vascular endothelial growth factor, and nerve growth factor all
phosphorylate tyrosines on p120 via src or a receptor tyrosine kinase; and epidermal
growth factor also induces extensive serine phosphorylation of p120.
Phosphorylation of the N-terminus of p120 may affect the function of p120.
Hypophosphorylated p120 facilitates cadherin clustering (97, 111), and
hyperphosphorylation of p120 inhibits cell-cell adhesion as does deletion of the Nterminus (72, 73). In the cytoplasm, p120 inhibits RhoA, but activates Rac1 and
Cdc42, which may increase cell motility (69). The cytoplasmic roles of p120 can be
regulated by cadherins, which are able to sequester it at cell junctions. Nuclear p120
binds to Kaiso, a novel transcriptional factor of POZ/ZF (Pox Virus and Zinc Finger)
family (101). Via its C-terminal C2H2-type zinc-finger motif, Kaiso can bind to a
specific DNA sequence and repress DNA transcription (90). Within the past two
years, a series of papers have highlighted the importance of p120 in the stabilization
and turnover of VE-cadherin (39, 80, 105). Collectively, these papers demonstrated
that binding of p120 to the juxtamembrane domain of cadherins regulates the protein
levels of these cadherins. Decreasing the protein level of p120 by siRNA or
overexpression of the juxtamembrane region of VE-cadherin reduces VE-cadherin
protein and decreases endothelial barrier function (39). Overexpression of p120 alone
or co-expression with the juxtamembrane region increases VE-cadherin and its
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localization at intercellular junctions. Therefore, stabilization of VE-cadherin relies
on the binding of p120. On the other hand, the lack of p120 binding targets VEcadherin to degradation through an endocytic pathway involving clathrin (106).
c. Rho Subfamily GTPases and Adherens Junctions
The Rho family of small GTPases belongs to the Ras superfamily, which is
composed of more than 50 members and has been divided into six families: Ras, Rho,
Arf, Sar, Ran, and Rab (94). At least 10 members of the Rho subfamily are known in
mammals: Rho A-E, Rho G, Rac1 and -2, Cdc42, and TC10. Rho A, -B, and -C, Rac
1 and-2, and Cdc42 are the best studied members, which exhibit guanine nucleotidebinding activity and function as molecular switches, cycling between an inactive
GDP-bound state and an active GTP-bound state. Dissociation of GDP is facilitated
by a guanine nucleotide exchange factor (GEF), and inhibited by a guanine nucleotide
dissociation inhibitor (GDI). Hydrolysis of bound GTP is accelerated a hundredfold
by a GTPase-activating protein (GAP) (47, 66). Rho small GTPases participate in
regulation of the actin cytoskeleton and various cell adhesion events. Rho has been
implicated in the formation of stress fibers and focal adhesions, cell aggregation, cell
motility, membrane ruffling, smooth muscle contraction, neurite retraction in neuronal
cells, and cytokinesis. Rac is involved in membrane ruffling, cell motility, actin
polymerization, and cadherin-mediated cell-cell adhesion. Cdc42 plays an important
role in the formation of filopodia, in cell motility, and in actin polymerization (28).
Rho family small GTPases regulate cadherin mediated cell-cell adhesions in
many ways (7, 31, 43, 95). Microinjection of dominant negative Rac1 (Rac1 N17) or
C3 botulinum exoenxyme, a RhoA inhibitor, reduced the level of cadherin at sites of
cell-cell contact upon Ca2+-induced intercellular adhesion in keratinocytes (7). In
contrast, Rac1 (wild-type, dominant-neg. or dominate-pos.) disrupts cell-cell
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adhesion in small preconfluent colonies of keratinocytes (6). Overexpression of
Rac1 N17 in MDCKII cells decreased the amounts of actin filaments, E-cadherin and
β -catenin to the cell-cell adhesion sites (95). Both Rac1 and Cdc42 are required for
E-cadherin-mediated cell-cell adhesion in MDCKII cells (43). Expression of Rac1
N17

and Cdc42 N17dramatically decreased E-cadherin-mediated cell adhesion in EL

cells (mouse L fibroblasts stably expressing wild-type E-cadherin) but not in nEαCL
cells (cells expressing an E-cadherin mutant in which the cytoplasmic domain was
replaced by the C-terminal domain of α-catenin), which suggests that Rac1 and
Cdc42 regulate E-cadherin activity through the cadherin-catenin complexes (21).
d. Adherens Junctions and Vascular Permeability
Although tight junctions have been considered the key regulators of barrier
function, at least in epithelial cells, the role of the adherens junction, in particularVEcadherin, in maintaining vascular integrity and permeability of vascular endothelia
has been proven by in vivo studies. Intravenous administration of mAb BV13, an
antibody against mouse VE-cadherin, induced an increase in vascular permeability
within a few hours in heart and lungs, but not in other organs, such as brain, muscles,
and skin (12). These findings indicate that the regulation of vascular permeability by
VE-cadherin may be cell and tissue specific but that vascular endothelial permeability
may also depend in some tissues on the type and organization of other intercellular
junctions like tight junctions.
3. Tight Junctions (Zonula Occludens)
Tight junctions appear to be a network of ridges under electron microscopy.
And each ridge is a continuous strand of transmembrane junctional proteins (protein
model) or lipid domains (lipid model) that bind tightly with those of another cell.
These ridges consist of occludin, claudins, and small junctional immunoglobulins

10

like Junctional Adhesion Molecule-A. Through their cytoplasmic tails, these integral
membrane proteins are associated with ZO-1, -2, -3, members of MAGUK
(Membrane Associated Guanylate Kinase) family, and are connected to actin
microfilaments. By occluding the lateral intercellular space, tight junctions restrict
both the diffusion of solutes across intercellular spaces (barrier function) and the
movement of membrane molecules between the apical and basolateral domains of the
plasma membrane (fence function). Therefore, tight junctions are important in
maintaining cell polarity and cell barrier function (4).
Tight junctions are found in both epithelial and endothelial cells. But in most
endothelial cells, adherens junctions are intermingled with tight junctions, and the
precise localization of tight junctions and their separation from other junctional
organelles is not as obvious as in epithelial cells. Also, there is considerable
endothelial heterogeneity along the vascular tree. For example, tight junctions are
well organized in arteries and arterioles, but less elaborate or loosely organized in
veins or postcapillary venules (4). Finally, tight junctions are well developed in
brain vessels, where they contribute to the blood-brain barrier, and less organized in
more leaky vessels (88).
4. Endothelial Junctions (Complexus Adherens)
Endothelial cells do not form desmosomes but instead have specific
endothelial junctions referred to as complexus adherens. This type of junction is
linked to intermediate filaments and expresses VE-cadherin instead of desmosomallike proteins. When bound to desmoplakin, VE-cadherin only associates with
intermediate filaments; when bound to plakoglobin, VE-cadherin can associate with
either intermediate filaments or actin microfilaments. Junctional Adhesion Molecules
and nectins support the formation of complexus adherens (83, 84).
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5. Immunoglobulin (IgG) Superfamily Adhesion Proteins
IgG superfamily of adhesion proteins are Ca2+-independent cell-cell adhesion
molecules (CAMs) and consist of junctional adhesion molecules (JAMs) and Ig cell
adhesion molecules (IgCAMs). JAMs are Ca2+-independent immunoglobulin (Ig)like cell-cell adhesion proteins, which localize to adherens, tight, and endothelial
junctions. JAMs (-A, -B, -C, -D) are comprised of two extracellular Ig folds, a
transmembrane domain and a short cytoplasmic tail. JAMs, except JAM-C, form
cis-dimers and mediate both homotypic and heterotypic interactions. JAM-B is
restricted to endothelial junctions, but JAM-A and –C also localize to immune cells.
JAMs are important for the formation of tight junctions, leukocyte transepithelial
migration, and platelet activation (3).
IgCAMs comprise a diverse group of adhesion receptors having one or several
Ig folds (41). Nectins are novel members of the IgCAMs family. Nectins form cisdimers and trans-dimers on the cell membrane and bind to the PDZ-containing
protein afadin (also called AF-6) inside the cell (92). Afadin binds ponsin, which in
turn connects the complex to actin microfilaments through α–catenin and vinculin.
Nectins act cooperatively with cadherins in adherens junctions of epithelial cells (Ecadherin) and fibroblasts (N-cadherin) and initiate the formation of adherens and
tight junctions (93). Therefore, the specific localization of these proteins at adherens
junctions may depend on the cell type and/or they may play a more general role in
the organization of both adherens and tight junctions.
Platelet endothelial cell-cell adhesion molecule (PECAM) is a transmembrane
immunoglobulin concentrated at intercellular contacts but not specifically confined
to adherens and tight junctions (64). PECAM mediates either homophilic or
heterophilic cell-cell adhesion. Intracellular binding partners of PECAM include

12

SHP-2 and β-catenin. SHP-2 may be involved in the Ras-mitogen-activated protein
kinase (MAPK) pathway (34). PECAM may act similarly as cadherin through its
binding to tyrosine phosphorylated β-catenin. Therefore, PECAM can modulate
cadherin-mediated cell-cell interactions through its interaction with β-catenin and
SHP-2. PECAM can also modulate cell adhesion with extracellular matrix and cell
migration through its interaction with integrins (35).

B. IQGAP1 and Adherens Junctions
1. Introduction
Although the molecular mechanism for the regulation of cell-cell adhesion is
largely unknown, IQGAP1 is now considered a key regulator. IQGAP1 (190 kDa) is
a scaffolding protein that has multiple protein-interacting domains (Fig. 1). Via the
calponin homology (CH) domain at the N-terminus, IQGAP1 binds to filamentous
actin and functions to cross-link and stabilize actin filaments (2, 57). Its IQ domain, a
tandem repeat of four IQ motifs, mediates the association of IQGAP1 with calmodulin,
myosin essential light chain, and S100B (a Zn2+-and Ca2+-binding protein) (53, 104).
Its G-protein binding domain (GRD) at the C-terminus binds to activated Rac and
Cdc42, but not RhoA or Ras (20, 23). IQGAP1 interacts with guanosine 5 -(3-O-thio)
triphosphate (GTP S)·glutathione S-transferase (GST)-Cdc42 and GTP S·GST-Rac1
but not with the GDP·GST-Cdc42, GDP·GST-Rac1, or GTP S·GST-RhoA) (44).
Through its C-terminal RasGAP domain, IQGAP1 binds directly to the adherens
junction proteins, E-cadherin and β-catenin, and co-localizes with these proteins at
cell-cell contacts in mouse L fibroblasts expressing E-cadherin (EL cells) and in
Madin Darby Canine Kidney (MDCK) epithelial cells (45). Via the RasGAP domain,
IQGAP1 also interacts with the microtubule-binding protein
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Figure 1. IQGAP1 structure and interacting proteins. IQGAP1 is a scaffolding
protein that has multiple protein-interacting domains. Via the calponin homology
(CH) domain at the N-terminus, IQGAP1 binds to filamentous actin and functions to
cross-link and stabilize actin filaments. Its IQ domain, a tandem repeat of four IQ
motifs, mediates the association of IQGAP1 with calmodulin, myosin essential light
chain, and S100B (a Zn2+-and Ca2+-binding protein). Its G-protein binding domain
(GRD) at the C-terminus binds to activated Rac and Cdc42, but not RhoA or Ras.
Through its C-terminal RasGAP domain, IQGAP1 binds directly to the adherens
junction proteins, E-cadherin and β-catenin. Via the RasGAP domain, IQGAP1 also
interacts with the microtubule-binding protein CLIP170 (cytoplasmic linker protein170).
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CLIP170 (cytoplasmic linker protein-170), capturing the growing microtubules at the
leading edge of migrating fibroblasts, resulting in cell polarization (23).
2. IQGAP1 and Cell-Cell adhesion
Kaibuchi et al. (22) and others (52) have demonstrated that the relative content
of IQGAP1 at the junction is important for the regulation of epithelial cell-cell
adhesion through its interaction with β-catenin, Rac1, and Cdc42. Overexpressed
IQGAP1 may inhibit E-cadherin-mediated cell-cell adhesion via its interaction with βcatenin, dissociating α-catenin from the cadherin-catenin complex in EL cells (45).
Activated Rac1 and Cdc42 may enhance E-cadherin-dependent cell adhesion by
inhibiting the interaction of IQGAP1 with β-catenin (21) (Fig. 2). In contrast,
treatment of MDCK cells with a phorbol ester reduces Rac1 activity, increases the
association of IQGAP1 with β-catenin, and displaces α-catenin from the adherens
junction (22). In vivo, IQGAP1 knockout had hardly any effect on the cadherin-based
adhesion of gastric cells in mice during embryogenesis, although it increased
susceptibility to gastric hyperplasia (51). Therefore, the physiological processes in
which IQGAP1 is involved needs to be determined. It would be interesting to
demonstrate the phenotype of mice transgenically engineered to overepxress the
IQGAP1 gene
3. IQGAP1 and Cell Migration
In general, directional cell migration begins with establishment of cell
polarization, which includes membrane ruffling, lamellipodia, and filopodia at the
leading edge, capture of microtubule plus-ends near the leading edge (which enables
motor proteins such as dynein and kinesin to perform directed membrane trafficking),
and reorientation of the microtubule-organizing center (MTOC) and the Golgi
apparatus towards the direction of migration. The resultant asymmetric distribution of
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Figure 2. Kaibuchi’s hypothesis: IQGAP1 inhibits cell-cell adhesion.
Overexpressed IQGAP1 inhibits E-cadherin-mediated cell-cell adhesion via its
interaction with β-catenin, dissociating α-catenin from the cadherin-catenin complex
in EL cells. Activated Rac1 and Cdc42 may enhance E-cadherin-dependent cell
adhesion by inhibiting the interaction of IQGAP1 with β-catenin.
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signaling molecules and the cytoskeleton facilitates the adherence of lamellipodia to
the substratum via focal adhesions. After the forward attachments have been made,
the bulk of the cytoplasm in the cell body flows forward. The trailing edge of the cell
remains attached to the substratum until the focal adhesions at the rear are broken and
the tail eventually detaches and retracts into the cell body. During this process, the
reorganization of the actin cytoskeleton and microtubules is very important and must
be well coordinated (26).
a. Rho GTPases, Cell Polarization and Directional Migration
In migrating cells, Cdc42 and Rac1 are localized at the leading edge of the
cells. The highest Cdc42 activity is at the tip of the leading edge, and the highest
Rac1 activity is very close to the leading edge (38). Only Cdc42 is found at the Golgi
apparatus, where it may regulate the secretory and endocytic transport of lipids and
proteins to the leading edge (42). Rho A mainly localizes to the cytosol and is
necessary and sufficient for lysophosphatidic acid-induced formation of detrypsinated
tubulin (Glu-tubulin), a post-translational modified form of tubulin that accumulates
in stable microtubules (10).
During cell polarization and migration, Rho GTPases capture and stabilize
microtubules through their effectors near the cell cortex. mDia2, a RhoA effector,
caps and stabilizes microtubules, and mDia1 induces longitudinal alignment of
microtubules in parallel to F-actin bundles along the long axis of the cell (37, 75).
Rac1 and Cdc42 can potentially stabilize microtubules through PAK, which
phosphorylates and inactivates stathmin, a microtubule-destabilizing protein (13).
Cdc42 can activate PKCξ, an atypical protein kinase C, through Par-6, leading to
phosphorylation and inactivation of GSK-3β at the leading edge. Inactivation of
GSK-3β removes the inhibition of APC, allowing it to stabilize microtubules at the
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leading edge (17, 18). APC can also interact with end-binding protein 1 (EB1), a
member of plus-end-tracking proteins (+Tips) that localize to the growing
microtubule plus end (17). As like other +Tips, such as the cytoplasmic linker protein
170 (CLIP-170) family and dynein-dynactin family, the EB1 family is necessary for
sensing cortical capture sites.
b. IQGAP1, Cell Polarization and Directional Migration
Fukata et al. (2002) found that activated Cdc42/Rac1 complexes with IQGAP1
and CLIP-170, enhancing the interaction between IQGAP1 and CLIP-170, and
recruiting green fluorescent protein (GFP)-CLIP-170 to the leading edge and the base
of filopodia. Watanabe et al. (2004) also showed that IQGAP1 directly interacts with
APC and both colocalize with Rac1 and Cdc42 at the leading edge. Therefore,
IQGAP1 may promote cell polarization and migration by stabilizing both
microfilaments and microtubules at the leading edge.
4. IQGAP1 and Distant Metastasis of Cancer Cells
In IQGAP1 knockout mice, a significant increase in late-onset gastric
hyperplasia relative to wild-type animals of the same genetic background was
observed (51). In human, gastric carcinoma is known to be associated with damage to
a small region on chromsome 15, where the IQGAP1 gene is located. And four
IQGAP1 mutations were found in multiple cases of highly invasive and metastatic
diffuse type gastric carcinoma. IQGAP1 was also upregulated by gene amplification
at 15q26 in two cell lines established from diffuse types of gastric carcinomas, HSC39
and 40A (91). Similary, IQGAP1 overexpression was found in human colorectal
carcinoma, particularly at the invasion front. Therefore, IQGAP1 is closely related to
invasion and distant metastasis of some carcinomas, but the exact mechanism is still
unknown.
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C. Sphingosine-1-Phosphate (S1P) and Cell-Cell Adhesion
1. Biosynthesis and Metabolism of S1P
Sphingosine-1-phosphate (S1P), a bioactive sphingolipid metabolite, is
generated from the metabolism of sphingomyelin upon cellular activation.
Specifically, sphingomyelinase degrades sphigomyelin to ceramide, which is then
degraded by ceramidase to sphingosine. Sphingosine kinase further converts
sphingosine to S1P. Alternatively, ceramide can be synthesized de novo by fumonisin
B1-sensitive ceramide synthase, which also contributes to S1P synthesis. Once
formed, S1P is rapidly degraded by S1P phosphatase and S1P lyase (89). Since
platelets have an abundance of sphingosine kinase and lack these S1P degradative
enzymes, platelets may release S1P in response to prothrombotic activation,
increasing the S1P level from 100 nM in plasma to 500 nM or even 1,000 nM in
serum.
2. G Protein-Coupled Receptors (GPCRs) for S1P: EDG Family
S1P acts as an extracellular mediator and an intracellular second messenger,
binding to seven transmembrane GPCRs and intracellular receptors, respectively.
GPCRs for S1P are five members of the EDG (or Endothelial Differentiation Gene)
family: EDG-1/S1P1, EDG-5/S1P2, EDG-3/S1P3, EDG-6/S1P4, and EDG-8/S1P5.
EDG-1 is a Gi-coupled receptor, through which S1P stimulates Rac1-induced
cortical actin formation and enhances motility (23). The EDG-1 cDNA was originally
isolated as a phorbol ester-induced immediate early transcript from vascular
endothelial cells, and EDG-1 protein plays a role in endothelial cell differentiation and
angiogenesis. EDG-5 is coupled to all G proteins, via which S1P induces stress fiber
formation by activating Rho, and inhibits cell migration by decreasing Rac1 activity.
And EDG-3 is coupled to Gi, Gq, and G12/13, via which S1P induces stress fiber
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formation by activating Rho, mediates neurite retraction and neuronal cell rounding,
suppresses Bax expression and activates endothelial nitric oxide synthase (eNOS) and
phosphatidylinositol 3-kinase (PI3K) (29).
As a second messenger, S1P can also promote cell proliferation and survival
by mobilizing calcium, activating extracellular signal regulated kinase (ERK),
andinhibiting c-Jun N-terminal kinase (JNK) activation. Thus, S1P can signal from
outside the cell via S1P (EDG) receptors and from inside the cell upon activation of
sphingosine kinase but can also be released from the cell and act on S1P receptors in
an autocrine and/or paracrine manner (30).
3. S1P Enhances Endothelial Barrier Function
Vascular endothelial cells primarily express receptors for EDG-1 (S1P1) and
EDG-3 (S1P3), but have little or no EDG-5 (S1P2) (55). Activation of EDG-1 and -3
promotes cell migration, vascular maturation, focal contact formation, and endothelial
barrier function. Reduction in EDG-1 expression attenuates barrier enhancement
induced by S1P, platelets, and platelet conditioned medium. In a mouse model of
acute lung injury (ALI), S1P attenuates the formation of lung edema in vivo (58, 77).
This effect of S1P on lung edema in vivo probably occurred via direct maintenance or
enhancement of the endothelial barrier as S1P prevented the 6-fold increase in
hydraulic conductivity induced by platelet-activating factor in venular microvessels of
the rat mesentery (62). This inhibitory effect of S1P was reversible and involved the
heterotrimeric G-protein, Gi.
S1P may affect the barrier function of the vascular endothelia by reorganizing
the cytoskeleton, strengthening adherens junctions, and/or remodeling focal adhesions.
To maintain an endothelial barrier, contractile forces, generated by the cytoskeleton,
must be balanced by tethering forces generated by adherens junctions and focal
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adhesions. S1P treatment induces the formation of a cortical actin ring and a rapid
redistribution of cortical actomyosin, phosphorylated myosin light chain (MLC), and
myosin light chain kinase (MLCK). MLC phosphorylation may promote the
interaction of myosin with actin filaments, stabilizing cortical cytoskeleton (25).
S1P of physiologic concentration (less than 1-2 μM) also activates Rac1 and Rho and
induces lamellipodia formation, membrane ruffling, cortical actin ring formation, and
cell spreading. Inhibition of Rac1 increases monolayer permeability and prevents the
translocation of cortactin to the periphery, reducing actin polymerization (102). Rac1
also activates p21activated kinase (PAK) subsequently phosphorylating LIM kinase
and causing the phosphorylation and inactivation of cofilin, an actin-severing protein.
Both PAK and cofilin translocated to the cell periphery after treatment with S1P (23).
Expression of a dominant-negative PAK-1 or wild-type cofilin reduced the increase in
cortical actin. The latter also blunted the increase in endothelial electrical resistance
induced by S1P. These authors concluded that a thickened, cortical actin plays a
prominent role in the enhanced endothelial barrier activity of S1P (23). Therefore,
inactivation of cofilin via Rac1 to PAK signaling may be key to the activity of S1P.
In confluent HUVECs, S1P also stimulates the localization of VE-cadherin
and α-, β-, and γ-catenins to sites of cell-cell contacts, forming functional adherens
junctions within 1 h in one report (50) and within 30 min in another report (59).
Dominant-negative Rac1 polypeptide prevented the S1P-induced localization of VEcadherin and β-catenin to intercellular junctions (50). S1P treatment also induces
tyrosine phosphorylation of FAK, breaking down focal adhesion complexes,
redistributing paxillin and focal adhesion kinase (FAK) to the periphery where they
associate with the cortical actin ring (86).
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Together these findings suggest that S1P increases the barrier function of the
vascular endothelia via a cell-signaling pathway involving the inhibitory G protein, Gi,
and Rac1 and via targets of the cytoskeleton such as cofilin, MLC, and MLCK and of
adherens junction proteins such as VE-cadherin and the catenins.
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II.

INTRODUCTION TO DISSERTATION STUDIES
Vascular endothelium, as a semi-permeable barrier, restricts the passage of

proteins from the blood to the extravascular compartment and also regulates many
biological processes such as inflammation, white cell emigration, and angiogenesis.
Disruption of the endothelial barrier leads to accumulation of fluid and
macromolecules in the interstitial space, resulting in edema and dysfunction of tissues
and organs. The junctional architecture between adjacent endothelial cells, comprised
of adherens junctions as well as tight junctions, contributes significantly to the
regulation of the endothelial barrier (4). The endothelial adherens junction,
containing primarily vascular endothelial (VE)-cadherin and catenins, has been
studied extensively. Modifications to VE-cadherin profoundly affect the integrity of
the endothelial barrier. For example, antibodies directed toward the extracellular
domain of VE-cadherin increased the permeability of endothelial cell monolayers (11)
and the vascular permeability in heart and lungs of mice (12). Endothelial cells also
contain tight junction proteins such as occludin, claudins, and ZO-1, but the effects of
these proteins on barrier function has been studied primarily in epithelial cells (4).
VE-cadherin is comprised of an extracellular domain, a transmembrane region,
a juxtamembrane region, and a highly conserved cytoplasmic tail (49, 101). In the
presence of Ca2+, extracellular domains of VE-cadherin of one cell bind to each other
forming cis-dimers, and those of adjacent cells bind head-to-head forming transdimers. The cytoplasmic tail of VE-cadherin binds β-catenin or γ-catenin or
plakoglobin, which in turn binds α-catenin to form a cadherin-catenin complex that
links to the actin cytoskeleton, although this latter linkage has recently been
challenged (16, 109). A fourth catenin, p120, binds to the juxtamembrane region of
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VE-cadherin, inducing stabilization of VE-cadherin (14, 39, 105) and cadherin
clustering (111), although this latter notion is controversial (72).
IQGAP1 is a scaffolding protein that binds directly to the adherens junction
proteins, E-cadherin and β-catenin, and co-localizes with these proteins at cell-cell
contacts in mouse L fibroblasts expressing E-cadherin (EL cells) and in Madin Darby
Canine Kidney (MDCK) epithelial cells (45). IQGAP1 also binds many other cellular
proteins via its multiple protein-interacting domains. Via the calponin homology
domain at the amino terminus, IQGAP1 binds to filamentous actin and functions to
cross-link and stabilize actin filaments (2, 8, 57). Its IQ domain mediates the
association of IQGAP1 with calmodulin (52, 104) and its G-protein binding domain
near the carboxy terminus binds to activated Rac1 and Cdc42 (21, 22).
The involvement of IQGAP1 in the dynamic regulation of epithelial adherens
junctions has been brought forth in a series of papers by Kaibuchi and co-workers (21,
22, 45, 71). These authors hypothesize that IQGAP1 overexpression inhibits Ecadherin-mediated epithelial cell-cell adhesion by dissociating β-catenin from αcatenin, thus disconnecting the VE-cadherin/β-catenin complex from the actin
cytoskeleton. Furthermore, activated Rac1 and Cdc42 may prevent these effects by
removing IQGAP1 from the complex (22, 45). The importance of the interaction of
IQGAP1 with E-cadherin or VE-cadherin, however, has not been determined and is
timely considering the recent papers by Yamada et al. (109) and Drees et al. (16).
These authors concluded that α-catenin does not bind simultaneously to the complex
of E-cadherin/β-catenin and to the actin cytoskeleton and that this purported linkage is
more dynamic than originally thought.
In initial experiments, I determined by immunoprecipitation and
immunofluorescence microscopy that IQGAP1 associated with the adherens junction
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proteins, VE- cadherin and the catenins, β, γ, α, and p120, but not with the tight
junction proteins, occludin, claudin-5, and ZO-1. To remove IQGAP1 from
junctional complexes, I activated Rac1 by S1P treatment and examined the
association of IQGAP1 with Rac1 and the presence of insoluble VE-cadherin and β–
catenin at intercellular junctions. Also, I significantly reduced the protein level of
IQGAP1 in human umbilical vein endothelial cells (HUVECs) by transfection of
small interfering RNA (siRNA) and determined the effect on basal electrical
resistance across cell monolayers by the measurement of electrical cell-substrate
impedance sensing (ECIS). Since IQGAP1 associated only with adherens junction
proteins and alterations in content of IQGAP1 have produced equivocal changes in Ecadherin or VE-cadherin in other cell types (45, 52, 70), I assessed the protein levels
of VE-cadherin and N-cadherin and the interactions of these two cadherins with the
catenins, p120, β, γ, and α, and with the insoluble cytoskeleton in IQGAP1
knockdown cells. To further determine the effect of IQGAP1 on the p120-VEcadherin association, a VE-cadherin-α-catenin fusion protein lacking β-catenin
binding sites was overexpressed in HUVECs and the distribution of IQGAP1 was
detected by immunofluorescence microscopy.
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III. MATERIALS AND METHODS

Materials. Fetal bovine serum was purchased from Atlanta Biologicals
(Norcross, GA), and gentamicin sulfate was from ICN Biomedicals, Inc (Aurora, OH).
Newborn calf serum and bovine brain extract were from Cambrex Corporation (East
Rutherford, NJ). Type I collagenase was from Worthington Biochemical Corporation
(Lakewood, NJ). MDCK (Madin-Darby Canine Kidney) cells (Catalog No. CCL-34)
were purchased from ATCC (Manassas, VA). Oligofectamine was from Invitrogen
(Carlsbad, CA). Control (scrambled) siRNA (SC-37007), IQGAP1 siRNA (SC35700), and polyclonal antibodies to VE-cadherin, IQGAP1, and p120 were from
Santa Cruz Biotechnology Inc (Santa Cruz, CA). Anti-β-actin monoclonal and anti-αcatenin polyclonal antibodies were from Alexis Biochemicals (San Diego, CA).
Monoclonal antibodies directed against IQGAP1, Rac1, N-cadherin, and γ-catenin
were from BD Biosciences (San Jose, CA). Polyclonal antibodies directed against
human occludin and ZO-1 and a monoclonal antibody to human claudin-5 were from
Zymed Laboratories (South San Francisco, CA). Anti-calmodulin and anti-IQGAP1
monoclonal (AF4) antibodies were from Upstate (Chicago, IL). Gold-coated ECIS
electrodes were from Applied Biophysics (Troy, NY). Sphingosine-1-Phosphate (S1P)
was from Avanti Polar Lipids, Inc. (Alabaster, AL). Peroxidase conjugated goat antimouse IgG, peroxidase conjugated goat anti-rabbit IgG, and peroxidase conjugated
rabbit anti-goat IgG antibodies were from Chemicon International, Inc. (Temecula,
CA). Alexa Fluor 488-labeled phalloidin, Alexa Fluor 594-labeled phalloidin, Alexa
Fluor 488-labeled goat anti-rabbit IgG, and Alexa Fluor 594-labeled goat anti-mouse
IgG were from Invitrogen Molecular Probes (Eugene, OR). Nitrocellulose
membranes and ECL (enhanced chemiluminescence) Western Blotting detection
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reagents were from Amersham Biosciences (Buckinghamshire, England), and a miniProtean electrophoresis system was from Bio-Rad Laboratories (Hercules, CA). All
other chemicals were from Sigma-Aldrich (St. Louis, MO).

Cell culture. HUVECs were isolated from fresh umbilical veins with 1 mg/ml
of type I collagenase and serially passaged and maintained in MCDB-131 containing
20% (v/v) newborn calf serum, 5% (v/v) human serum, 7.5 μg/ml of endothelial cell
growth supplement, 4.5 μg/ml of bovine brain extract, 20 μg/ml of porcine intestinal
heparin, and 50 μg/ml of gentamicin sulfate. All experiments were performed on
HUVECs passaged less than 8x. MDCK cells were cultured in Dulbecco’s modified
Eagles medium containing 10% fetal bovine serum.

Transfection. IQGAP1 siRNA was transfected into HUVECs with
oligofectamine. Briefly, HUVECs were seeded on 0.2% gelatin-coated 6-well culture
dishes or on ECIS wells and grown to 50-80% confluence. IQGAP1 siRNA (0.27 to
0.40 µM) or scrambled siRNA was transfected into cells with oligofectamine in
serum-free MCDB-131 for 4 h. In most experiments, fresh HUVEC growth medium
was added, and cells were placed in a humidified environment and maintained at 37 º
C and 5% CO2 for 2-3 d. Although this transfection protocol resulted in a significant
dilution of the oligofectamine, this lipd carrier was not removed by washing and there
was concern about adverse effects of the remaining oligofectamine, especially if lipid
micells were formed. Therefore, some of the experiments were repeated whereby cell
monolayers were washed with culture medium after the initial 4 h- transfection period,
then incubated in fresh culture medium for the remainder of the experiment.
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Assessment of endothelial barrier function by ECIS. Continuous measurement
of electrical resistance across HUVEC monolayers with ECIS was used to assess
changes in endothelial barrier function (24). HUVECs (50,000-100,000 cells) were
seeded onto ECIS cultureware (0.8 cm2/well) precoated with 0.2% gelatin for 24 h.
The measured electrical resistance is of those cells located on the small gold electrode
(5 x 10

4

cm2) in each of the wells. The culture medium was the electrolyte, and the

small gold electrode, covered by confluent endothelial cells, and a larger gold counterelectrode (~2 cm2) were connected to a phase-sensitive, lock-in amplifier. A 1-V,
4,000-Hz alternating current signal was supplied through a 1-M resistor to
approximate a constant current source of 1 µA. The computer controlled the output of
the amplifier and switched the measurements to different electrodes in each of two 8well arrays during the course of an experiment. The small size of the cell-seeded
electrode is the critical feature of the system. When electrodes of 10
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cm2 or smaller

are used, the impedance at the small electrode dominates the system, allowing the
morphology of the cells located at this interface to be assessed. Electrical resistance of
the bare electrode is ~2,000 ohms and increases to 8,000 to 10,000 ohms or greater
when HUVECs have become confluent. Using a cell-covered electrical resistance of
7,000 ohms, corrected for the bare electrode, and the electrode surface area of 5 x 10-4
cm2, the basal electrical resistance across the HUVEC cell monolayer is less than 5
ohms•cm2 (98).
For experiments with S1P, HUVECs (100,000 cells) were seeded onto ECIS
cultureware, then carefully washed 3x with MCDB-131 cell culture medium and
incubated in MCDB-131 medium without serum for 2 h. After these cells were
treated with 1 μM S1P (once or 7x, 10 min each) or BSA as a control, transcellular
electrical resistance was continuously measured for 2.5 h.
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The method of transfection of IQGAP1 siRNA and measurement of electrical
resistance were conducted in two different ways: either cells were seeded on 6-well
culture dishes, transfected, re-seeded on ECIS wells, and monitored for changes in
endothelial electrical resistance or cells were directly seeded on ECIS wells,
transfected, and monitored for changes in electrical resistance. In the first method,
oligofectamine was removed by the process of reseeding cells from the culture dish to
the ECIS wells, as compared to the second protocol where oligofectamine, albeit in a
diluted concentration, remained in the ECIS wells. One rationale for not changing the
medium was not to disturb the continuous measurement of electrical resistance.
For the experiments with the infection of the adenoviral recombinant fusion
protein, VE-cadherin-α-catenin, HUVECs were grown on ECIS cultureware with 10
instead of 1 small gold electrode. In these 10-electrode wells, the electrical resistance
signal is averaged among the 10 electrodes, and the baseline electrical resistance is
lower than the 1-electrode wells.

Immunoprecipitation and immunoblotting. Cells were washed 2x in ice-cold
phosphate buffered saline (PBS), lysed in buffer containing 30 mM 4-(2hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES, pH 7.4), 50 mM NaCl, 1%
Triton X-100, 10% glycerol, 1 mM ethylene glycol-bis(2-aminoethylether)N,N,N’,N’-tetraacetic acid (EGTA), 1 mM sodium vanadate, 10 mM
phenylmethanesulfonyl fluoride (PMSF), and 10 μg/ml of leupeptin. Samples were
clarified by centrifugation at 14,000 x g for 5 min at 4º C, and one-tenth of the whole
cell lysate was saved for immunoblotting. Nine-tenth of the total cell lysate was
immunoprecipitated overnight at 4º C with indicated antibodies. Immune complexes
were collected with protein A- and G-Sepharose. After centrifugation, samples were
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washed 3x with lysis buffer. Proteins were resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS-PAGE) and transferred to Nitrocellulose
membrane using a mini-Protean electrophoresis system. Polyacrylamide gels (7.5%)
were used to detect IQGAP1, VE-cadherin, N-cadherin, the catenins, β-, γ-, α-, p120
and ZO-1, and 12% gels were used to detect occludin and claudin-5. Blots were
probed with indicated primary antibodies, followed by the appropriate horseradish
peroxidase-conjugated secondary antibody, and developed by enhanced
chemiluminescence.
Immunocytochemistry and confocal microscopy. HUVEC monolayers were
fixed in 4% formaldehyde in PBS for 15 min and permeabilized in PBS containing
0.18% Triton X-100 for 15 min. Fixed cells were stained with the indicated primary
antibodies for 1 h and incubated with Alexa Fluor 488-labeled goat anti-rabbit IgG
and/or Alexa Fluor 594-labeled goat anti-mouse IgG for 30 min. Actin filaments
were fluorescently stained with Alexa Fluor 488- or 594-labeled phalloidin. Images
were generated by confocal laser scanning with a Zeiss LSM 510 upright confocal
microscope. For the same group of images, the fluorescent signals were measured at
emission wavelengths of 488 and 594 nm with the same pinhole (less than 1 μm) and
the same detector gain, as well as the same amplifier offset. For all of the images,
multitracking was used to prevent crosstalk of signals between channels, and the
bandwidth of the emission filters was narrowed to avoid bleed-through from one
channel to another.
Cytoskeleton preserving buffer containing 0.5% Triton X-100 (CSK-Tx buffer)
was used to extract soluble proteins not linked to the cytoskeleton under near
physiological conditions of ionic strength and pH, and the Triton X-100-insoluble
proteins consistes of 65% of the total cell protein (19). Cells were first permeabilized
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in ice-cold CSK-Tx buffer (10 mM PIPES, pH 6.8, 3 mM MgCl2, 100 mM NaCl, and
300 mM sucrose) for 1 min and then fixed in 4% formaldehyde in PBS for 15 min.
Fixed cells were then processed as described above.

Infection. HUVECs were seeded onto precoated glass coverslips for 24 h,
then confluent HUVEC monolayers were infected with an adenoviral construct
expressing green fluorescent protein (GFP)-labeled VE-cadherin-α-catenin fusion
protein for 48 h. This adenoviral recombinant lacked the β-catenin binding site on
VE-cadherin and on α-catenin. Immunfluorescent staining was performed as
described above.

Statistics. All values in the text are means ± SE. Data on the quantification of
immunoblots were analyzed with a single sample t-Test. Data on electrical resistance
were analyzed with a 2-way analysis of variance with repeated measures. Differences
between treatments at specific time points were further analyzed with a Bonferroni
post-test. Significance was set at P<0.05.
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IV. RESULTS

S1P rapidly increased the electrical resistance across HUVEC monolayers.
S1P has been shown previously to enhance the barrier function of endothelial
monolayers, as assessed by an increase in electrical resistance (25). I initially
confirmed this result by the measurement of transcellular electrical resisatance using
ECIS. After treatment with various doses of S1P, electrical resistance across HUVEC
monolayers increased rapidly, peaked at 10 min, and gradually came back to the
baseline level after 1 h. Electrical resistance across cell monolayers treated with the
vehicle BSA did not change (Fig. 3A).
Increasing or decreasing the dosage of S1P (0.1 μM -10 μM) from 1 μM did
not change the response pattern, which suggests that the S1P response is not dose- or
time-dependent. Since S1P can be rapidly degraded by S1P phosphatase and S1P
lyase, we also administered 1 μM S1P 7x every 10 min for 1 h to maximize the
downstream effects of S1P. The repeated treatments of S1P every 10 min maintained
the peak resistance for 1 h. Once the S1P treatment was stopped, however, electrical
resistance gradually decreased to the baseline level after 1 h. Electrical resistance
across cell monolayers treated with BSA (7x, 10 min each) was not significantly
changed (Fig. 3B).

S1P increased insoluble VE-cadherin and insoluble β-catenin at intercellular
junctions in confluent cell monolayers.
One potential mechanism for the S1P-induced increase in endothelial electrical
resistance is an increase in homophilic VE-cadherin binding. To look at this possible
effect of S1P on the adherens junctions, cytoskeleton preserving buffer containing
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Figure 3. S1P rapidly increased transcellular electrical resistance. HUVEC
monolayers grown on ECIS cultureware (0.8 cm2/well) were carefully washed 3x with
MCDB-131 culture medium and incubated in MCDB-131 medium without serum for
2 h. After these cells were treated with 1 μM S1P (one or 7x, 10 min each) or BSA as
a control, transcellular electrical resistance was continuously measured for 2.5 h. A)
After S1P treatment, the electrical resistance across HUVEC monolayers increased
rapidly, peaked at 10 min, and gradually came back to baseline value after 1 h.
Electrical resistance across control cell monolayers treated with BSA did not change
(n=8). B) Repeated S1P treatments (7x) every 10 min maintained the peak resistance
for 1 h. Once the S1P treatment was stopped, the electrical resistance gradually came
back to the baseline value after 1 h. The resistance across control cell monolayers
treated with BSA was not significantly changed (n=6).
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0.5% Triton X-100 (CSK-Tx buffer) was used to extract soluble proteins not linked to
the cytoskeleton, as previously described by Nagafuchi and Takeichi (65). After the
challenge of Triton X-100, some of the VE-cadherin and β-catenin, presumably the
soluble proteins, were removed from cell-cell contacts, but insoluble VE-cadherin and
β-catenin, defined as being bound to the actin cytoskeleton and forming strong cellcell adhesions, remained at intercellular junctions. Within 10 min of S1P treatment,
more insoluble VE-cadherin and β-catenin were localized at intercellular junctions as
compared to the BSA control treatment (Fig. 4A), which suggests that S1P rapidly
increased the interaction of the VE-cadherin/β-catenin complex to the insoluble
cytoskeleton and possibly also increased the amount of VE-cadherin and β-catenin at
intercellular junctions.

Furthermore, S1P also prevented the formation of gaps

between cells, which indicates a stronger cell-cell adhesion (Fig. 4B).

S1P translocated Rac1 to the periphery of cells and increased the association
of Rac1 with IQGAP1.
Rac1 has been implicated in tightening of the adherens contacts (20), and S1P
is known to increase the activity of Rac1 . Immunocytochemistry studies showed that
S1P treatment translocated Rac1 from the cytoplasm to the cell periphery (Fig. 5B).
Previous studies by Kaibuchi and co-workers (21) have demonstrated in epithelial
cells that active Rac1 interacts with IQGAP1. To determine if Rac1 activated by S1P
interacts with IQGAP1 in endothelial cells, HUVECs were seeded on 6-well dishes
for 24 h and treated with BSA or 1 μM S1P for 10 min. Cells were lysed in
immunoprecipitation buffer and one-tenth of the whole cell lysate was saved for
immunoblotting. The rest of the cell lysate was immunoprecipitated for IQGAP1 or
IgG as a control, and then immunoblotted for Rac1. Association of IQGAP1 with

37

Figure 4

38

Figure 4. S1P increased insoluble VE-cadherin and insoluble β-catenin at
intercellular junctions. Confluent HUVEC monolayers grown on glass coverslips
were treated with 1 μM S1P for 10 min or with BSA as a control. cells were
permeabilized first (CSK-Tx) with cytoskeleton preserving buffer containing 0.5%
Triton X-100 to extract soluble proteins before application of primary antibodies to
VE-cadherin and β-catenin. After S1P treatment, insoluble VE-cadherin and βcatenin were increased as compared to BSA treatment. Magnification bar =10 μm.
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Figure 5. S1P increased IQGAP1 association with Rac1. A) HUVECs were lysed
in immunoprecipitation buffer and one-tenth of the whole cell lysate was saved for
immunoblotting. The rest of the cell lysate was immunoprecipitated for IQGAP1 or
IgG as a control, and then immunoblotted for Rac1. Association of IQGAP1 with
Rac1 was dramatically increased at 10 min after S1P treatment, and the protein level
of Rac1 in each group of cells was similar. B) Cells were fixed and incubated with
anti-IQGAP1 polyclonal and anti-Rac1 monoclonal antibody, which were visualized,
respectively, with Alexa Fluor 488-labeled goat anti-rabbit IgG (green) and Alexa
Fluor 594-labeled goat anti-mouse IgG (red). S1P induced the translocation of Rac1
to intercellular junctions, where Rac1 colocalized with IQGAP1. Magnification bar
= 10 μm.
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Rac1 was increased nearly 4 fold within 10 min of S1P treatment (Fig. 5A).
Immunocytochemistry studies showed that S1P induced co-localization of Rac1 and
IQGAP1 at the cell periphery, which also suggests that S1P treatment increased the
association of Rac1 with IQGAP1.

IQGAP1 colocalizes with Rac1 at membrane ruffles and in the cytoplasm of
subconfluent cells, and complexes with calmodulin in the cytoplasm of HUVECs.
In subconfluent cells, IQGAP1 and Rac1 colocalized in the cytoplasm and at
the membrane ruffles of untreated cells (Fig. 6). For both subconfluent and confluent
cells, IQGAP1 colocalized with calmodulin in the cytoplasm but not at the periphery
of cells (Fig. 7B).

Co-immunoprecipitaton showed that calmodulin specifically

complexed with IQGAP1 in HUVECs (Fig. 7A).

Insoluble IQGAP1 colocalizes with actin filaments at leading edges of
subconfluent cells.
In subconfluent cells, IQGAP1 colocalized with actin filaments (phalloidin
stained) at the membrane ruffles of cell leading edges (Fig. 8A). Triton extraction did
not remove IQGAP1 at the membrane ruffles, which suggested that IQGAP1 at the
leading edge of the cell is insoluble and bound to the cytoskeleton (Fig. 8B).

Interaction of IQGAP1 with VE-cadherin and catenins at cell-cell contacts.
IQGAP1 associates with E-cadherin and catenins in epithelial cell, so I
initially determined by immunoprecipitation and immunofluoresence microscopy if
IQGAP1 associates with proteins of the adherens junction in HUVECs. Control cell
lysates were incubated with an antibody to IQGAP1 or IgG, the latter to determine
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Figure 6. IQGAP1 colocalized with Rac1 at membrane ruffles and in the
cytoplasm in subconfluent monolayers. Subconfluent cell monolayers were fixed
and stained with anti-IQGAP1 polyclonal and anti-Rac1 monoclonal antibodies,
which were visualized, respectively, with Alexa Fluor 488-labeled goat anti-rabbit
IgG (green) and Alexa Fluor 594-labeled goat anti-mouse IgG (red).

IQGAP1

colocalized with Rac1 at both membrane ruffles and in the cytoplasm of the
subconfluent cells. Magnification bar = 10 μm.
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Figure 7. IQGAP1 complexed with calmodulin in the cytoplasm. A) HUVEC cell
lysate was immunoprecipitated for IQGAP1 or IgG as a control, and then
immunoblotted for calmodulin. IQGAP1 specifically associated with calmodulin but
not the IgG control.

B) Both confluent and subconfluent cells were fixed and

incubated with anti-IQGAP1 polyclonal and anti-calmodulin monoclonal antibody,
which were visualized, respectively, with Alexa Fluor 488-labeled goat anti-rabbit
IgG (green) and Alexa Fluor 594-labeled goat anti-mouse IgG (red).

For both

subconfluent and confluent cells, IQGAP1 colocalized with calmodulin in the
cytoplasm but not at the periphery of cells. Magnification bar = 10 μm.
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Figure 8.

Insoluble IQGAP1 colocalized with actin filaments at membrane

ruffles of subconfluent cell monolayers. Subconfluent HUVEC monolayers grown
on glass coverslips were fixed first (Control) or permeabilized first (CSK-Tx) with
cytoskeleton preserving buffer containing 0.5% Triton X-100 to extract soluble
proteins before application of an anti-IQGAP1 antibody and phalloidin.

In

subconfluent cells, IQGAP1 colocalized with actin filaments (phalloidin stained) at
the membrane ruffles of the leading edges of cells. IQGAP1 at the membrane ruffles
was Triton-insoluble. Magnification bar = 10 μm.
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antibody specificity. Immunoprecipitates were resolved by SDS-PAGE and probed
with antibodies to VE cadherin and the catenins, β, γ, α, and p120. These proteins
formed specific complexes with IQGAP1 in HUVEC monolayers (Fig. 9 A-E).
Localization of IQGAP1 in confluent endothelial cell monolayers was also viewed by
immunofluorescence microscopy following co-incubation with primary antibodies to
IQGAP1 and VE-cadherin, or one of the catenins, β, γ, α, or p120 (Fig. 9 F-J), or
calmodulin, or Rac1. IQGAP1 was localized in the cytoplasm and at cell-cell contacts
(Fig. 9, IQGAP1). In the cytoplasm, IQGAP1 was evenly distributed and partially colocalized with Rac1 and calmodulin (Fig. 5,7). At the cell periphery, IQGAP1 colocalized with VE-cadherin and the catenins (Fig. 9 F-J, Merged).

IQGAP1 did not complex with the tight junction proteins, occludin, claudin-5,
and ZO-1.
Since there are no reports of the association of IQGAP1 with tight junction
proteins, I measured the protein levels of occludin, claudin-5, and ZO-1 in HUVECs
and MDCK cells by immunoblotting, localized these proteins in the cells by
immunofluorescence microscopy, and finally determined if these proteins associated
with IQGAP1 in HUVECs by immunoprecipitation. Low protein levels of occludin
and ZO-1 were present in HUVECs as compared with MDCK cells (Fig. 10 A, B).
The protein level of claudin-5, an endothelial-specific member of the claudin family,
was also low in HUVECs (Fig. 10 A, B). Compared to the immunofluorescent
staining of IQGAP1, staining of occludin was very weak. Both claudin-5 and ZO-1
localized at intercellular junctions, but neither protein associated with IQGAP1, as
depicted by immunoprecipitation or immunofluorescence microscopy (Fig. 10C).
Junctional IQGAP1 was detergent extractable.
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Figure 9. Interaction of IQGAP1 with VE-cadherin and catenins, β, γ, α, and
p120. HUVEC lysates were immunoprecipitated with antibodies to IQGAP1 or IgG.
A-E) Representative immunoblots from three independent experiments demonstrated
that IQGAP1 associates with VE-cadherin and catenins, β, γ, α, and p120. F-J)
Confluent HUVEC monolayers were processed for immunofluorescence microscopy
using monoclonal antibodies visualized with Alexa Fluor 594-labeled goat anti-mouse
IgG (red) or polyclonal antibodies visualized with Alexa Fluor 488-labeled goat antirabbit IgG (green). Note co-localization of IQGAP1 with VE-cadherin and all four
catenins (Merged). Magnification bars = 10 μm.
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Figure 10. IQGAP1 did not complex with tight junction proteins, occludin,
claudin-5, and ZO-1. A, B) MDCK and HUVEC lysates were probed with
antibodies to occludin and ZO-1. Representative immunoblots (A) and quantification
after normalization to β-actin of four independent immunoblots (B) demonstrated that
protein levels of occludin and ZO-1 were low in HUVECs, as compared to MDCK
cells. C) HUVEC lysates were immunoprecipitated with antibodies to IQGAP1 or
IgG and immunoblotted with antibodies to occludin, claudin-5, and ZO-1.
Representative immunoblots from four independent experiments demonstrated that
IQGAP1 did not associate with occludin, claudin-5, and ZO-1 in HUVECs. Confluent
HUVEC monolayers were also processed for immunofluorescence microscopy using
monoclonal antibodies visualized with Alexa Fluor 594-labeled goat anti-mouse IgG
(red) or polyclonal antibodies visualized with Alexa Fluor 488-labeled goat anti-rabbit
IgG (green). Note that claudin-5 and ZO-1 were observed at intercellular junctions,
whereas occludin staining was weak as compared to IQGAP1 staining. Magnification
bars = 10 μm.
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To determine whether the IQGAP1 observed at intercellular junctions
complexes with adherens junction proteins associated with the insoluble cytoskeleton,
HUVEC monolayers were permeabilized first with CSK-Tx buffer to remove soluble
proteins and then fixed with 4% paraformaldehyde. In control cells, both IQGAP1
and VE-cadherin were co-localized at cell-cell contacts (Fig. 11A, Control). After
removal of soluble proteins by permeabilization with Triton X-100, most of the
IQGAP1 was absent from intercellular junctions (Fig. 11A, CSK-Tx) and no longer
co-localized with insoluble (cytoskeletal-associated) VE-cadherin (Fig. 11A, CSK-Tx)
or β-catenin. A few strands of IQGAP1 at the cell periphery (Fig. 11A, IQGAP1 and
CSK-Tx) were resistant to detergent extraction. Junctional IQGAP1 did not
colocalize with the cortical actin ring in control cells. But in Triton-treated cells, most
of the junctional IQGAP1 was extracted, and the remaining insoluble IQGAP1 colocalized with the peripheral ring of actin just interior to the cell membrane (Fig. 12).
Reduction of IQGAP1 by siRNA.
HUVECs were seeded on 6-well dishes and transfected with IQGAP1 siRNA
or scrambled siRNA by using oligofectamine. After 48 h of transfection with
IQGAP1 siRNA, the protein level of IQGAP1 was reduced by 75% (Fig. 13 A and B).
Reduction of IQGAP1 by siRNA was also observed by immunofluorescence
microscopy with an anti-IQGAP1 polyclonal antibody. HUVECs were transfected
with IQGAP1 siRNA or scrambled siRNA in 6-well dishes. After 48 h, cells were
trypsinized and reseeded onto precoated glass coverslips for another 24 h. IQGAP1
siRNA, as compared with scrambled siRNA, dramatically reduced the
immunofluorescent staining of IQGAP1 (Fig. 13C). The protein level of IQGAP1
was also reduced at 24 and 72 h after transfection with IQGAP1 siRNA (Fig. 14A).
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Figure 11. IQGAP1 was Triton-soluble at intercellular junctions. Confluent
HUVEC monolayers grown on glass coverslips were fixed first (Control) or
permeabilized first (CSK-Tx) with cytoskeleton preserving buffer containing 0.5%
Triton X-100 to extract soluble proteins before application of primary antibodies to
IQGAP1 and VE-cadherin. Junctional IQGAP1 was sensitive to Tritonpermeabilization, whereas VE-cadherin was more resistant (CSK-Tx versus Control).
Note co-localization (Merged) of IQGAP1 and VE-cadherin in Control column but
not in CSK-Tx column. Magnification bars = 10 μm.
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Figure 12. Junctional IQGAP1 colocalized with cortical actin filaments after
permeabilization.

Confluent HUVEC monolayers grown on glass coverslips were

fixed first (Control) or permeabilized first (CSK-Tx) with cytoskeleton preserving
buffer containing 0.5% Triton X-100 to extract soluble proteins before application of
antibodies to IQGAP1 and phalloidin. Junctional IQGAP1 did not colocalize with
cortical actin ring in control cells, but after Triton-treatment, IQGAP1 co-localized
with peripheral ring of actin just interior to the cell membrane. Magnification bars =
10 μm.

58

Figure 13

*

59

Figure 13. Reduction of IQGAP1 by siRNA. HUVEC monolayers were
transfected by oligofectamine with 0.4 μM IQGAP1 siRNA or scrambled siRNA. A)
Representative immunoblot demonstrated reduction of IQGAP1 by siRNA. B)
Quantification of IQGAP1 after normalization to β-actin demonstrated reduction of
IQGAP1 in cells transfected with IQGAP1 versus scrambled siRNA (n = 16). C)
Immunofluorescent staining of IQGAP1 was dramatically reduced in cells transfected
for 72 h with IQGAP1 siRNA. ∗P<0.05 vs. scrambled siRNA (open bar).
Magnification bars = 10 μm.
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Figure 14. Toxicity and Knockdown Effect of IQGAP1 siRNA. A) HUVEC
monolayers were transfected by oligofectamine with 0.27 μM IQGAP1 siRNA or
scrambled siRNA for 24h, 48h, or 72h, and then equal volume of cell lysates were
loaded. Representative immunoblot demonstrated that IQGAP1 protein level was
reduced by siRNA after 24h, 48h, and 72h. B) HUVEC monolayers were not
transfected, or treated only with oligofectamine, or transfected by oligofectamine with
0.27 μM IQGAP1 siRNA or scrambled siRNA, and then equal volume of cell lysates
were loaded. Representative immunoblot demonstrated reduction of IQGAP1 by
siRNA and no change in the protein levels of β-actin.
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Reduction of IQGAP1 was specific to transfection with IQGAP1 siRNA as
cells transfected with a scrambled siRNA and oligofectamine alone had protein levels
of IQGAP1 that were no different from untreated cells (Fig. 14 B). No significant
cellular toxicity was detected by comparing the levels of IQGAP1 and β-actin in
HUVECs that were untreated, oligofectamine-treated, or transfected with scrambled
siRNA (Figs. 13A and 14A-B).
Basal electrical resistance was higher in IQGAP1 knockdown cells.
According to the hypothesis of Kaibuchi and co-workers (71), the binding of
IQGAP1 to β-catenin disrupts the adherens junction and causes separation between
adjacent cells. To determine if a reduction in IQGAP1 would induce the opposite
result, an increase in endothelial barrier function, HUVECs were transfected directly
on ECIS wells with 0.27 µM IQGAP1 siRNA or scrambled siRNA in MCDB-131
containing oligofectamine (Fig. 15A). Electrical resistance across cell monolayers
was continuously measured by ECIS. Basal electrical resistance of both siRNAtransfected groups started at ~ 9,000 ohms. In IQGAP1 knockdown cells, electrical
resistance remained fairly constant, and from 60-80 h after transfection there was an
~2,000 ohms difference between the IQGAP1 siRNA group and the scrambled siRNA
(Fig. 15A). The above findings were confirmed by transfecting HUVECs in 6-well
dishes for 48 h, trypsinizing, seeding the scrambled siRNA- or IQGAP1 siRNAtransfected cells on ECIS wells, and continuously monitoring electrical resistance for
an additional 50 h.

After 48 h of transfection and within five hours of seeding on the

ECIS wells, electrical resistance of HUVEC monolayers was 8,200 and 6,700 ohms,
respectively, for the IQGAP1 siRNA- and scrambled siRNA-treated groups (Fig.
15B). This difference of ~1,500 ohms in electrical resistance increased to ~2,200
ohms at 58 h and then decreased to ~1,400 ohms by 73 h after transfection. After
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ECIS, cells on the active electrode were immunostained for IQGAP1 to demonstrate
reduction of this protein by siRNA and for VE-cadherin to count the cells and exclude
any gain or loss of cells in both groups (Fig. 15 B). With both methods of
transfection, basal electrical resistance was higher from 50 to 80 h after transfection
with IQGAP1 siRNA. It also important to note that similar responses were observed
in cell monolayers either continuously exposed to a diluted concentration of
oligofectamine (Fig. 15A) or having had oligofectamine removed during the process
of reseeding the cells on the ECIS wells (Fig. 15B).
IQGAP1 knockdown increased VE-cadherin.
To begin to understand the cellular mechanism for the higher endothelial
electrical resistance in IQGAP1 siRNA-treated cells, I measured the protein level of
VE-cadherin in both IQGAP1 siRNA- and scrambled siRNA-transfected cells after 48
h of transfection. A representative immunoblot (Fig. 16A) and quantification of four
immunoblots (Fig. 16B) from individual experiments demonstrated that IQGAP1
knockdown increased the protein level of VE-cadherin by almost 80%, as compared
to transfection with a scrambled siRNA. In these initial experiments, cell monolayers
were exposed continuously to a diluted concentration of oligofectamine for 44 h. To
remove any potential adverse effects of oligofectamine, these experiments were
repeated in cell monolayers in which oligofectamine was removed by washing at 4 h
after the transfection period. The protein level of IQGAP1 increased in two of the
three experiments in cell monolayers transfected with IQGAP1 siRNA, as compared
to the levels in cells that were untreated, oligofectamine alone-treated, and scrambled
siRNA-treated (Fig. 16 C and D). In the third experiment, similar levels of IQGAP1
protein were observed in all four groups (Fig. 16E).
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Figure 15. Basal electrical resistance was higher in IQGAP1 knockdown cells. A)
HUVEC monolayers seeded in ECIS (Electric Cell-substrate Impedance Sensing)
wells were transfected with 0.27 μM IQGAP1 or scrambled siRNA and continuously
monitored by ECIS. Basal electrical resistance of cell monolayers was higher in
IQGAP1 knockdown cells compared to scrambled siRNA- transfected cells (n = 17).
B) HUVEC monolayers were transfected in 6-well dishes for 48 h, then trypsinized
and seeded in ECIS wells. Basal electrical resistance of HUVEC monolayers was
higher in cells transfected with IQGAP1 siRNA than with scrambled siRNA (n = 7).
Inserts are representative micrographs of ECIS wells incubated with anti-IQGAP1
antibody after ECIS experimentation of cell monolayers transfected with IQGAP1 or
scrambled siRNA. ∗P<0.05 vs. scrambled siRNA (open squares) at specific time
points.
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To observe the localization of the increased VE-cadherin in IQGAP1
knockdown cells, HUVECs were untreated, oligofectamine-treated, scrambled
siRNA-treated, or IQGAP1 siRNA-treated in 6-well dishes for 48 h, then trypsinized
and seeded them on precoated glass coverslips for another 24 h to form confluent cell
monolayers. Cell monolayers were fixed (Fig. 16F) and incubated with an anti-VEcadherin antibody to visualize VE-cadherin by immunofluorescence microscopy.
Similar cell densities were observed in these groups, and no significant difference in
the amount or localization of VE-cadherin was observed among these groups.
IQGAP1 knockdown decreased N-cadherin.
Interestingly, the protein level of N-cadherin was decreased by 75% in
HUVECs transfected with IQGAP1 siRNA for 48 h under the condition of continuous
exposure to diluted oligofectamine for 44 h (Fig. 17 A and B). Following the repeat
of these experiments in cell monolayers washed of oligofectamine, the protein level of
N-cadherin was decreased in three of three experiments (Fig. 17C-E).

IQGAP1 knockdown did not change protein levels of p120-, β-, γ-, and αcatenins.
In contrast to the changes in protein levels for VE- and N-cadherins, protein
levels of the catenins, p120, β, γ, and α, were unchanged in IQGAP1 knockdown cells
(Fig. 18 A and B). Neither the distribution patterns nor the intensities of p120- β-, γ-,
and α-catenins as visualized by immunofluorescence microscopy was changed after
reduction of IQGAP1 (Fig. 18 C-E).

N-cadherin associated with catenins (p120, β, γ, α) but not VE-cadherin or
IQGAP1.
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Figure 16. IQGAP1 knockdown increased VE-cadherin. HUVEC monolayers
were transfected with IQGAP1 or scrambled siRNA, and cell lysates were probed
with primary antibodies to IQGAP1, VE-cadherin, and β-actin. A,B) Representative
immunoblot and quantification after normalization to β-actin of four independent
immunoblots demonstrated that IQGAP1 knockdown increased protein level of VEcadherin (VE-Cad). C-E) VE-cadherin protein level was also measured inHUVECs
were untransfected, oligofectamine-treated, scrambled siRNA-treated, or IQGAP1
siRNA-treated in 6-well dishes for 4h. The protein level of VE-cadherin increased in
two of the three experiments in cell monolayers transfected with IQGAP1 siRNA, as
compared to the levels in cells that were untreated, oligofectamine alone-treated, and
scrambled siRNA-treated (C, D). In the third experiment, similar levels of IQGAP1
protein were observed in all four groups (E). F) HUVECs were untransfected,
oligofectamine-treated, scrambled siRNA-treated, or IQGAP1 siRNA-treated in 6well dishes for 48 h, trypsinized, and then seeded onto precoated glass coverslips for
another 24 h to form confluent cell monolayers. Cells were fixed and incubated with
anti-VE-cadherin antibody followed by goat anti-rabbit IgG conjugated to Alexa
Fluor 488. No significant difference was observed among these groups. ∗P<0.05 vs.
respective scrambled siRNA (open bars).
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Figure 17. IQGAP1 knockdown decreased N-cadherin. HUVEC monolayers
were transfected with IQGAP1 (IQ) or scrambled siRNA, and cell lysates were
probed with primary antibodies to IQGAP1, N-cadherin, and β-actin. A,B)
Representative immunoblot and quantification after normalization to β-actin of four
independent immunoblots demonstrated that IQGAP1 knockdown decreased protein
level of N-cadherin. C-E) N-cadherin protein level was also measured inHUVECs
were untransfected, oligofectamine-treated, scrambled siRNA-treated, or IQGAP1
siRNA-treated in 6-well dishes for 4h. The protein level of N-cadherin decreased in
all of the three experiments in cell monolayers transfected with IQGAP1 siRNA, as
compared to the levels in cells that were untreated, oligofectamine alone-treated, and
scrambled siRNA-treated. ∗P<0.05 vs. respective scrambled siRNA (open bars).
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Figure 18. IQGAP1 knockdown did not change protein levels of p120-, β-, and αcatenins. HUVEC monolayers were transfected with IQGAP1 (IQ) or scrambled
siRNA, and cell lysates were probed with primary antibodies to IQGAP1, catenins
(cat), p120, β, and α, and β-actin. A, B) Representative immunoblot and
quantification after normalization to β-actin of four independent immunoblots
demonstrated that protein levels of catenins were unchanged in IQGAP1 knockdown
cells. C, D, E) Both scrambled and IQGAP1 siRNA-transfected cells were stained for
IQGAP1, catenins, p120, β, and α, which were visualized with Alexa Fluor 488labeled goat anti-rabbit IgG (green) and Alexa Fluor 594-labeled goat anti-mouse IgG
(red), respectively. Although IQGAP1 siRNA dramatically decreased the intensity of
IQGAP1 staining, it did not change the intensities of p120-, β-, and α-catenin staining.
∗

P<0.05 vs. respective scrambled siRNA (open bars).
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To determine the interaction of N-cadherin with adherens junction proteins,
we incubated cell lysates with antibodies to IQGAP1, VE-cadherin, p120-, β-, γ-, and
α-catenins, and IgG. Immunoprecipitates were resolved by SDS-PAGE and probed
with an anti-N-cadherin antibody. N-cadherin associated with p120-, β-, γ-, and αcatenins, but not with VE-cadherin or IQGAP1 (Fig. 19A). We conclude that Ncadherin forms similar complexes as VE-cadherin, but N-cadherin does not directly
associate with IQGAP1.
N-cadherin was also distinguished from VE-cadherin with regard to the
interaction with the insoluble cytoskeleton. Cells were either fixed first (Fig. 19B,
Control) or permeabilized first (Fig. 19B, CSK-Tx) before administration of
antibodies to VE- and N-cadherins. In control cells, both VE-cadherin and Ncadherin were present at intercellular junctions (Fig. 19B, Control). After removal of
soluble proteins by detergent extraction, less N-cadherin was observed at intercellular
junctions than VE-cadherin (Fig. 19B, CSK-Tx). These observations suggest that
VE-cadherin is linked to a greater extent than N-cadherin to the insoluble
cytoskeleton. Since the linkage of cadherins to the actin cytoskeleton is thought to be
essential for the formation of a strong intercellular adhesion, these findings would
indicate that VE-cadherin mediates a much stronger cell-cell adhesion than Ncadherin.
IQGAP1 knockdown increased association of VE-cadherin with p120- and βcatenins; opposite response occurred with N-cadherin.
Next, I determined if the reduction in IQGAP1 affected the association of VEcadherin and N-cadherin with the catenins. Lysates from HUVECs transfected with
IQGAP1 siRNA or scrambled siRNA for 48 h were incubated with antibodies to p120
or β-catenin. The resultant immunoprecipitates were subjected to SDS-PAGE and
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Figure 19
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Figure 19. N-cadherin formed complexes with all four catenins and was less
bound to cytoskeleton. A) HUVEC lysates were immunoprecipitated with
polyclonal antibodies to IQGAP1, VE cadherin, p120, α-catenin, or IgG or
monoclonal antibodies to β-catenin or γ-catenin and probed with an anti-N-cadherin
monoclonal antibody. N-cadherin formed immunocomplexes with catenins, p120, β,
γ, and α, but not VE-cadherin or IQGAP1. Data represent three independent
experimental determinations. B) Cells were fixed first (Control) or permeabilized
first (CSK-Tx) and incubated with anti-VE-cadherin polyclonal and anti-N-cadherin
monoclonal antibody, which were visualized, respectively with Alexa Fluor 488labeled goat anti- rabbit IgG (green) and Alexa Fluor 594-labeled goat anti-mouse
IgG (red). Both N-cadherin and VE-cadherin were located at intercellular junctions .
Note that more VE-cadherin was resistant to extraction with Triton X-100 than Ncadherin (CSK-Tx). Magnification bars = 10 μm.
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probed with antibodies to VE-cadherin, N-cadherin, and β- and α-catenins.
Association of VE-cadherin with p120 was increased by almost 50% (Fig. 20 A and B)
and that with β-catenin by ~60% (Fig. 20 C and D). In contrast, the associations of
N-cadherin with both p120 (Fig. 20 A and B) and β-catenin (Fig. 20 C and D) were
decreased by 50%. Associations of p120 with β-catenin (Fig. 20 A and B) and of βcatenin with α-catenin (Fig. 20 C and D) were not changed by transfection with
IQGAP1 siRNA. The increased and decreased associations of p120 and β-catenin
with VE-cadherin and N-cadherin, respectively, were in line with the increased
protein level of VE-cadherin and the decreased protein level of N-cadherin in
IQGAP1 knockdown cells.
Expression of fusion protein, VE-cadherin-α-catenin, increased the electrical
resistance across HUVECs.
To determine the targets of IQGAP1 in the adherens junctional complex, I
infected cells with an adenoviral construct expressing GFP-labeled VE-cadherin-αcatenin as a fusion protein, which consists of amino acids (aa) 1-701 of VE-cadherin
and aa 320-906 of α-catenin. Since the binding sites of β-catenin in both VE-cadherin
and α-catenin were deleted, β-catenin cannot bind to this exogeneous fusion protein.
By immunoblotting, a GFP-labeled protein at 140 kD was found in infected cells but
not in the control cells with equal loading of protein (Fig. 21B).
To detect the functional role of this fusion protein, confluent HUVEC
monolayers were adenovirally infected with the construct expressing the VE cadherinα-catenin fusion protein on ECIS (8W10) cultureware, and electrical resistance across
cell monolayers was continuously measured. During the first 48 h, electrical
resistance of the PBScontrol group was maintained around 900 ohms, wherease the
electrical resistance of the VE-cadherin-α-catenin treated group started at 1,000 ohms
80

Figure 20
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Figure 20. IQGAP1 knockdown increased association of VE-cadherin with p120
and β-catenin; opposite effect occurred with N-cadherin. HUVECs were seeded
on 6-well dishes for 24 h, and transfected with scrambled or IQGAP1 siRNA for
another 48 h. HUVEC lysates were immunoprecipitated with an anti-p120 polyclonal
or an anti-β-catenin monoclonal antibody, and probed with antibodies to VE-cadherin,
N-cadherin, β-catenin, and α-catenin. Representative immunoblots (A,C) and
quantification of three independent immunoblots after normalization to β-actin (B,D)
demonstrated that reduction of IQGAP1 increased and decreased, respectively,
associations of p120 (A,B) and β-catenin (C,D) with VE-cadherin (VE-cad) and Ncadherin (N-cad). Association of p120 with β-catenin (β-cat, A,B) or β-catenin with
α-catenin (α-cat, C,D) did not change. ∗P<0.05 vs. respective scrambled siRNA (open
bars).
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and reached 1,400 ohms. Thus, the basal electrical resistance contributed by control
cells was increased 55% by infection of VE-cadherin-α-catenin. From 48 h to 72 h,
electrical resistance was increased in both groups, but the resistance of the VEcadherin-α-catenin treated group was still 400 ohms higher than that of the control
group. Therefore, overexpressed VE-cadherin-α-catenin increased the basal electrical
resistance of HUVEC monolayers (Fig. 21C).
VE-cadherin-α-catenin expression diminished IQGAP1 located at intercellular
junctions.
In the attempt to increase the p120-VE-cadherin association, confluent
HUVEC monolayers grown on glass coverslips were infected with an adenoviral
construct expressing GFP-labeled VE-cadherin-α-catenin fusion protein for 48 h, then
fixed and stained for p120, β-catenin, and IQGAP1. In cells expressing VE-cadherinα-catenin, p120 colocalized with GFP-labelled VE-cadherin-α-catenin at intercellular
junctions; fewer β-catenin molecules colocalized with GFP-labelled VE-cadherin-αcatenin than p120; and most of the junctional IQGAP1 was diminished in cells
expressing VE-cadherin-α-catenin (Fig. 22).
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Figure 21
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Figure 21. VE-cadherin-α-catenin expression increased the electrical resistance
across HUVECs.

A) Confluent HUVEC monolayers were infected with an

adenoviral construct expressing green fluorescent protein (GFP)-labeled VE-cadherinα-catenin fusion protein for 48 h. Cell lysates were immunoblotted for GFP, and a
GFP-labelled protein at 140KD was found in infected cells but not in the control cells
with equal loading of proteins. B) Confluent HUVEC monolayers were infected with
the construct expressing VE cadherin-α catenin fusion proteins on 8W10
culturewares, and electrical resistance across cell monolayers was continuously
measured. During the first 48 h, electrical resistance of the PBS control group was
maintained around 900 ohms, whereas the resistance of the VE cadherin-α catenin
treated group started at 1,000 ohms and reached 1,400 ohms.

The basal electrical

resistance contributed by control cells was increased 55% by VE cadherin-α catenin
infection. From 48 h to 72 h, electrical resistance was increased in both groups and
the resistance of VE cadherin-α catenin treated group was still 400 ohms higher than
that of the control group.
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Figure 22
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Figure 22. VE-cadherin-α-catenin expression diminishes junctional IQGAP1.
HUVECs were seeded onto precoated glass coverslips for 24 h, then the confluent
HUVEC monolayers were infected with an adenoviral construct expressing green
fluorescent protein (GFP)-labeled VE-α-catenin fusion protein for 48h. After fixation,
these cells were stained for p120, β-catenin, or IQGAP1. In cells expressing VEcadherin-α-catenin, p120 colocalized with GFP-labelled VE-cadherin-α-catenin at
intercellular junctions. Less β-catenin colocalized with GFP-labelled VE-cadherin-αcatenin at intercellular junctions than p120.

And most junctional IQGAP1 was

diminished in cells expressing VE-cadherin-α-catenin. Magnification bar = 10 μm.
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V. DISCUSSION
I demonstrated in this dissertation that 1) S1P increased the association of
IQGAP1 with Rac1, 2) S1P increased insoluble VE-cadherin and β-catenin at
intercellular junctions, 3) IQGAP1 was associated with proteins comprising the
endothelial adherens junction, i.e. VE-cadherin and the catenins, 4) a reduction in
IQGAP1 enhanced the integrity of the endothelial barrier, 5) IQGAP1 knockdown
increased the protein level of VE-cadherin and the interaction of VE-cadherin with
p120- and β-catenins, and 6) IQGAP1 knockdown decreased the protein level of Ncadherin and the interaction of N-cadherin with p120- and β-catenins. IQGAP1 at
intercellular junctions appeared to be soluble in its association with VE-cadherin but
insoluble in its association with the actin ring structure just adjacent to the cell
periphery. N-cadherin formed complexes with p120-, β-, γ-, and α-catenins but not
with VE-cadherin or IQGAP1. After detergent extraction, more insoluble VEcadherin and less N-cadherin were observed at intercellular junctions in HUVECs,
indicating that VE-cadherin associates to a greater extent than N-cadherin with the
insoluble cytoskeleton. Low levels of the tight junction proteins, occludin, claudin-5,
and ZO-1, as compared to the levels in MDCK cells, were observed in HUVECs, and
these proteins were not complexed with IQGAP1. We suggest that IQGAP1
knockdown can enhance the barrier function of vascular endothelia by increasing the
protein level of VE-cadherin and the association of VE-cadherin with β-catenin and
the actin cytoskeleton. The increased interaction of p120 with VE-cadherin could also
contribute to the enhanced barrier function via stabilization and an increase in VEcadherin protein. As a result of the decrease in N-cadherin, more p120 and β-catenin
may be available to interact with VE-cadherin.
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Junctions between endothelial cells consist of tight junctions and adherens
junctions. And expression and organization of tight junctions and adherens junctions
varies in endothelial cells at different locations in the vascular tree. In HUVECs, I
found that the protein levels of occludin and ZO-1 were much lower than those in
MDCK cells that have fully developed and well-organized, tight junctions. Compared
to the level of β-actin, the relatively low protein levels of claudin-5, occludin, and
ZO-1 in HUVECs indicate that tight junctions are poorly organized in HUVECs.
Although claudin-5 and ZO-1 were found at intercellular junctions, IQGAP1 did not
co-immunoprecipitate with these proteins, which suggests that IQGAP1 does not
complex with these proteins. Therefore, we conclude that tight junctions are less
expressed and organized in HUVECs and that IQGAP1 does not interact with tight
junction proteins in endothelial cells.
According to the Kaibuchi hypothesis, the association of IQGAP1 with Ecadherin and β-catenin can be disrupted by GTP-bound Rac1 (21). Since S1P has
been shown to activate Rac 1, I hypothesized that S1P treatment may also disrupt the
IQGAP1-VE-cadherin association. I first looked at the S1P effect on endothelial cellcell adhesion, and found that S1P treatment rapidly increased the electrical resistance
across HUVEC monolayers, confirming an earlier reported finding (Garcia). This
S1P effect was diminished within 1 h, and the S1P response was not affected by
changing the S1P dose from 0.1 μM to 10 μM, which may be due to a negative
feedback mechanism or the metabolism of S1P. To further explore the mechanism, I
gave S1P every 10 min for 1 h and found that repeated S1P treatments every 10 min
maintained the peak resistance. Maintenance of the response would argue against
internalization of the Edg-receptor. However, the increased electrical resistance did
slowly decline over the period of the seven treatments of S1P, which might argue for
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a slow internalization of the receptors. A more likely explanation isthat termination
of the S1P effect was due to the metabolism of S1P, possibly by phosphatases and/or
lysases in the serum.
Since S1P treatment rapidly enhanced the endothelial barrier, I further
explored its effect on adherens junctions and found that S1P increased insoluble VEcadherin and insoluble β-catenin at intercellular junctions in confluent cell
monolayers, which indicates that S1P induces the formation of more adherens
junctions bound to actin cytoskeleton. And S1P treatment also prevented formation of
gaps between cells during the permeabilization and processing procedures for light
microscopy, which indicates a stronger cell-cell adhesion. The finding that S1P
increased insoluble VE-cadherin and insoluble β-catenin at intercellular junctions
confirms the previous reports (46, 56) that S1P increased the localization of junctional
VE-cadherin and the catenins within 30-60 min of treatment. Dominant-negative
Rac1 polypeptide prevented the S1P-induced localization of VE-cadherin and βcatenin to intercellular junctions (50). However, in the present study, S1P increased
the amount of junctional VE-cadherin as well as β-catenin within 10 min, which
temporally corresponds with the rapid increase in electrical resistance that peaks
around 10 min after treatment with S1P. S1P also translocated Rac1 to the periphery
of cells and increased the association of Rac1 with IQGAP1, as demonstrated by coimmunoprecipitation and immunofluorescence microscopy. Together, these findings
suggest that S1P may increase insoluble VE-cadherin and β-catenin by activating
Rac1 and dissociating IQGAP1 from adherens junction complexes. However, there
was no microscopical verification of a reduction in IQGAP1 at intercellular junctions
upon treatment with S1P.
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To further characterize IQGAP1 in endothelial cells, I found that IQGAP1
colocalizes with Rac1 at membane ruffles and with Rac1 and calmodulin in the
cytoplasm of subconfluent cells.

In subconfluent cells, IQGAP1 colocalized with

actin filaments (phalloidin stained) at the membrane ruffles of the leading edges of
cells. Triton extraction did not remove IQGAP1 at the membrane ruffles, which
suggests that these proteins are insoluble and bound to the cytoskeleton. Mataraza et
al. (53) found that overexpression of IQGAP1 in Swiss 3T3 cells enhanced cell
migration in a Cdc42- and Rac1-dependent manner, and knock down of IQGAP1
decreased cell motility.

Fukata et al. (2002) found that activated Cdc42/Rac1

complexes with IQGAP1 and CLIP-170, enhancing the interaction between IQGAP1
and CLIP-170, and recruiting GFP-CLIP-170 to the leading edge and the base of
filopodia. Watanabe et al. (2004) also showed that IQGAP1 directly interacts with
APC and both colocalize with Rac1 and Cdc42 at the leading edge. Therefore,
IQGAP1 may promote cell polarization and migration by stabilizing both
microfilaments and microtubules at the leading edge.
IQGAP1 binds to E-cadherin and β-catenin, but not to α-catenin, in L cells
expressing E-cadherin (EL cells) (45). In MDCK cells, IQGAP1 co-localizes with αcatenin as viewed by immunofluorescence microscopy (44) and interacts at its
carboxy terminal domain with β-catenin and E-cadherin (8, 71). Upon binding to βcatenin, IQGAP1 competitively interferes with the binding of α-catenin to the Ecadherin/β-catenin complex and dissociates cell-cell contacts, presumably by
unlinking the complex from the actin cytoskeleton (22, 45). The content of IQGAP1
at epithelial adherens junctions appears to be determined by the activity of Rac1 or
Cdc42. Treatment of MDCK cells with a phorbol ester reduces Rac1 activity,
increases the association of IQGAP1 with β-catenin, and displaces α-catenin from the
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adherens junction (22). The opposite response occurs upon activation of Rac1 or
Cdc42, i.e. removal of IQGAP1 from the cadherin-catenin complex and enhancement
of cell-cell contacts (21, 45). IQGAP1 also binds avidly to calmodulin. An
antagonist of calmodulin induced the disassociation of IQGAP1 from calmodulin and
increased the association of IQGAP1 with E-cadherin at the periphery of MCF-7
human breast epithelial carcinoma cells (52). Together, these findings indicate that
IQGAP1 can interact with proteins in the cytoplasm and at the plasma membrane
where IQGAP1 can regulate the epithelial adherens junction.
In HUVECs, I found that IQGAP1 formed complexes with VE-cadherin and
β-, γ-, α-, and p120-catenins at cell-cell contacts. Furthermore, the IQGAP1
associated with junctional VE-cadherin appeared to be soluble, i.e. not bound to the
cytoskeleton, as Triton X-100 extracted most of the IQGAP1, except for a few strands,
at the cell periphery. This observation supports Kaibuchi’s hypothesis that soluble
IQGAP1 interacts with and can be removed from adherens junction proteins, thus
contributing to the dynamic regulation of the adherens junction (46, 71). There was
also a ring of IQGAP1 just interior to VE-cadherin that was resistant to detergent
extraction, thus considered insoluble, and was co-localized with the peripheral band of
actin. IQGAP1 did not interact with N-cadherin. Under control conditions, Ncadherin was located diffusely throughout the endothelial cell (67, 82) and also
localized at intercellular junctions (56). Using co-immunoprecipitation, we found that
all of the catenins, p120, β, γ, and α, formed complexes with N-cadherin but that VEcadherin and IQGAP1 did not.
I found an inverse relationship between the protein levels of VE-cadherin and
N-cadherin after transfection with IQGAP1 siRNA. The protein level of VE-cadherin
was increased and that of N-cadherin decreased after the reduction of IQGAP1 in
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HUVECs. The protein levels of the catenins, p120, β, γ, or α, were unchanged.
Although there were changes in protein levels, as determined by Western blotting, no
changes in the amount or localization of these protein, the cadherins and catenins,
were observed by light microscopy. In other cell types, varying the content of
IQGAP1 at intercellular junctions has produced varying results in terms of the protein
level of E-cadherin. Reduction of IQGAP1 by siRNA decreased the accumulation of
E-cadherin, β-catenin, and actin filaments at contacts between MDCK cells (71).
IQGAP1 knockdown also decreased VE-cadherin at cell-cell contacts in HUVECs,
but did not change the protein level of VE-cadherin (110). Translocation of IQGAP1
from calmodulin present in the cyptoplasm to E-cadherin at the cell membrane,
induced in MCF-7 cells by a calmodulin antagonist, decreased the level of E-cadherin
(52). Overexpression of IQGAP1, however, did not change the protein level of Ecadherin and α- or β-catenin in EL cells (45). Our findings of an inverse relationship
of the protein levels of VE- and N-cadherins is also in contrast to the findings of Luo
and Radice (56) who observed that a reduction of N-cadherin by siRNA led to a
decrease in VE-cadherin as well as p120 in HUVECs.
The above finding of an inverse relationship in the protein levels of VE- and
N-cadherin following a reduction of IQGAP1 was observed initially in cell
monolayers continuously exposed to a diluted concentration of oligofectamine.
Because continuous exposure of oligofectamine, which could have formed micells
even if diluted, may adversely effecte the cells, the above experiments were repeated
after removing the oligofectamine by washing at 4h after the transfection period.
Similar findings were observed as above in three additional experiments; protein level
of VE-cadherin increased in two of three experiments and the proten leve of Ncadherin decreased in three of three experiments.
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There was also an inverse relationship in the associations of p120 and βcatenin with VE-cadherin and N-cadherin in IQGAP1 knockdown cells. VE-cadherin
interacted to a greater and N-cadherin to a lesser extent with p120 and β-catenin. This
makes sense, as there would be more VE-cadherin protein to interact with these
catenins and vice versa for N-cadherin. However, within the past two years, a series
of papers have highlighted the importance of p120 in the stabilization and turnover of
VE-cadherin (14, 39, 105, 106). Collectively, these papers demonstrated that binding
of p120 to the juxtamembrane domain of cadherins regulates the protein levels of
these cadherins. Decreasing the protein level of p120 by siRNA or overexpression of
the juxtamembrane region of VE-cadherin reduced VE-cadherin protein and
decreased endothelial barrier function (39). Overexpression of p120 alone or coexpression with the juxtamembrane region increased VE-cadherin and its localization
at intercellular junctions. Therefore, stabilization of VE-cadherin relies on the
binding of p120. On the other hand, the lack of p120 binding targets VE-cadherin to
degradation through an endocytic pathway involving clathrin (106). Interestingly, Ncadherin may participate in this regulation. Unpublished observations by a
collaborator (Dr. Peter Vincent, Albany Medical College) indicated that
overexpression of N-cadherin induces a decrease in VE-cadherin, and p120 associates
preferentially with the increased N-cadherin. Although not addressed in this study,
the increased associations of p120- and β-catenins with VE-cadherin could have
resulted from removing a potential antagonistic effect of IQGAP1 on the binding of
these two catenins to VE-cadherin. Also, the decreased association of these two
catenins with N-cadherin may have resulted in the increased availability of these
catenins for VE-cadherin.

94

IQGAP1 knockdown had a positive influence on basal barrier function, as
assessed by the continuous measurement of electrical resistance across HUVEC
monolayers. Endothelial electrical resistance was higher in those cell monolayers
transfected with IQGAP1 siRNA as compared with transfection of a scrambled
siRNA. The potential mechanism for this positive effect on barrier function may be
an increase in homophilic VE-cadherin binding between adjacent endothelial cells.
This notion is supported by the demonstrations in IQGAP1 knockdown cells of an
increased protein level of VE-cadherin and association of VE-cadherin with β-catenin.
In contrast to the findings for VE-cadherin, the protein level of N-cadherin and the
association of N-cadherin with β-catenin were decreased, and N-cadherin was less
resistant to detergent extraction in IQGAP1 knockdown cells. I conclude from these
findings that an increased linkage of VE-cadherin and/or a decreased linkage of Ncadherin to the cytoskeleton contributed to the higher electrical resistance in IQGAP1
knockdown cells.
The increased association of p120 with VE-cadherin could also induce lateral
clustering or cis-dimerization of adjacent VE-cadherins (111) and/or could stabilize
VE-cadherin protein (14, 39, 105), both effects having a positive influence on the
endothelial barrier. Equivocal results, however, have been obtained with regard to
p120 and its role in cell-cell adhesion. Whereas in some studies the juxtamembrane
region of the cadherins and in particular p120 was found to enhance cell-cell adhesion
and maintain the cobble-stone morphology of cell monolayers (97, 111), other studies
have concluded that the juxtamembrane region and p120 prevent lateral clustering of
the cadherins (72). The amino-terminus of p120 may be the key to this adhesive
activity as it contains a number of phosphorylation residues for tyrosine and
serine/threonine that appear to effect cell-cell adhesion (72, 73).
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Vice versa, an increased presence of IQGAP1 at adherens junctions might
decrease VE- or E-cadherin and increase N-cadherin; an inverse relationship that
characterizes the migratory phenotype of epithelial cells when they transition from
epithelium to mesenchymal or fibroblast-like cells. IQGAP1 has been identified as
one of many cell-adhesion-related genes upregulated by transforming growth factor β,
a known mediator of epithelial to mesenchymal transition (107). IQGAP1 is also
expressed in poorly differentiated adenocarcinomas (63) and in diffuse-type gastric
tumors exhibiting impaired cell-cell adhesion (96) and has been implicated in cohort
migration of carcinoma cells (87). Our findings of an inverse relationship in the
expression of VE-cadherin and N-cadherin coupled with enhancement of endothelial
barrier function further implicate the involvement of IQGAP1 in adhesive activities
between endothelial cells.
The presence of IQGAP1 at the cell periphery may destabilize the adherens
junction by interfering with the association of VE-cadherin with p120 or β-catenin.
By infecting HUVECs with an adenoviral construct expressing a GFP-labeled VEcadherin-α-catenin fusion protein, which lacks the β-catenin binding domain on VEcadherin and α-catenin, I found that expression of the VE-cadherin-α-catenin fusion
protein increased endothelial electrical resistance, which may be due to more VEcadherin on the membrane and more VE-cadherin linked to the actin cytoskeleton,
similar to the outcomes mediated by IQGAP1 knockdown, or an enhanced interaction
of α-catenin to the actin cytoskeleton. Localization of GFP expression with p120, βcatenin, and IQGAP1 by immunofluorescence microscopy revealed that GFP and
p120 were co-localized. The staining of β-catenin was low and not co-loclized with
GFP and probably only represented endogenous β-catenin. There was minimal to no
staining of IQGAP1, similar to the results observed in IQGAP1 knockdown cells.
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The low level of IQGAP1 staining is to be expected since the fusion protein lacks any
of the binding sites for β-catenin. However, it is also possible that expression of the
VE-cadherin-α-catenin fusion protein caused a reduction in localization of IQGAP1 at
intercellular junctions as the increase in binding of p120 to the fusion protein
competitively excluded IQGAP1. This would be the expected result if one of the
primary binding site for IQGAP1 on VE-cadherin is the p120-binding domain on the
juxtamembrane region of VE-cadherin, indicatinge that IQGAP1 mainly targets at the
p120-VE-cadherin association in the complex. Although IQGAP1 has been reported
to bind VE-cadherin at the carbocy terminus of IQGAP1 (Kaibuchi, Sacks), the
binding site on VE-cadherin has yet to be determined.
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VI. CONCLUSION
Reduction of IQGAP1 by siRNA increased the basal electrical resistance
across endothelial cell monolayers in association with increases in the protein level of
VE-cadherin and the associations of VE-cadherin with p120 and β-catenin as well as
the cytoskeleton. Based on these findings in IQGAP1 knockdown cells, it is attractive
to hypothesize, as depicted in Figure 23, that the overexpression of IQGAP1 at
endothelial adherens junctions disrupts the binding of p120 and β-catenin to VEcadherin, causing the destabilization of VE-cadherin and a decrease in VE-cadherin
protein. The end result might be a decrease in endothelial barrier function.
Furthermore, activation of Rac1 by S1P might remove IQGAP1 from adherens
junctions, promoting the binding of p120 to VE-cadherin, and thus stabilizing VEcadherin, increasing its linkage to the actin cytoskeleton, and enhancing endothelial
cell-cell adhesion.
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Figure 23. Our hypothesis. In human umbilical vein endothelial cells (HUVECs),
IQGAP1 disrupts the association of p120 with VE-cadherin, destabilizing endothelial
adherens junctions, decreasing VE-cadherin and increasing N-cadherin.
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